Prof. Dr.

Yener Koç

PUBLICATIONS :

301, h-index 31, Citations 4332

 

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the …

A Nagler, M Labopin, D Blaise, AM Raiola, LL Corral, S Bramanti, S Sica, ...

Journal of Hematology & Oncology 16 (1), 1-152023

 

Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission …

Y Ye, M Labopin, J Chen, Z Gulbas, X Zhang, Y Koc, D Blaise, F Ciceri, ...

 

Journal of Hematology & Oncology 16 (1), 1-52023

Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From

Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First …

MA Kharfan-Dabaja, M Labopin, E Ayala, A Bazarbachi, D Blaise, J Vydra, ...

HemaSphere 7 (7) 2023

 

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation

W Arcese, Y Koc, J Tischer, D Blaise, Z Gülbas, M Teresa, V Lint, B Bruno, ...2023

 

Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant …

A Nagler, M Labopin, R Swoboda, A Kulagin, H Labussière-Wallet, ...

Bone marrow transplantation 58 (5), 552-5572023

 

Sequential vs Myeloablative vs Reduced Intensity Conditioning for Patients with Myelodysplastic Syndromes with an excess of blasts at time of allogeneic haematopoietic cell …

V Potter, L Gras, A van Biezen, N Kroeger, K Sockel, A Ganser, J Finke, ...2023

 

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With …

SJF Hermans, J Versluis, M Labopin, S Giebel, Y Van Norden, I Moiseev, ...

HemaSphere 7 (3 )2023

 

Non-T Depleted Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Secondary Versus De Novo AML: A Study from the Acute Leukaemia Working …

A Nagler, M Labopin, D Blaise, AM Raiola, LL Corral, S Bramanti, S Sica, ...

2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …2023

 

Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

N Santoro, JE Mooyaart, R Devillier, Y Koc, J Vydra, L Castagna, ...

Bone Marrow Transplantation 58 (1), 119-120 2023

 

Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

N Santoro, JE Mooyaart, R Devillier, Y Koc, J Vydra, L Castagna, ...

Bone Marrow Transplantation 58 (1), 54-60 2023

 

Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia …

A Spyridonidis, M Labopin, E Brissot, I Moiseev, J Cornelissen, G Choi, ...

Bone marrow transplantation 57 (12), 1774-1780 2022

 

Comparable Outcomes Following Non-First-Degree and First-Degree Related Donor Haploidentical Hematopoietic Cell Transplantation for Acute Leukemia Patients in Complete …

Y Ye, M Labopin, J Chen, Z Gulbas, X Zhang, Y Koc, D Blaise, F Ciceri, ...

Blood 140 (Supplement 1), 10603-10605 2022

 

Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic …

A Nagler, M Labopin, M Arat, P Reményi, Y Koc, D Blaise, E Angelucci, ...

Cancer 128 (22), 3959-3968 2022

 

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute …

F Baron, M Labopin, J Tischer, F Ciceri, AM Raiola, D Blaise, S Sica, ...

Bone Marrow Transplantation 57 (11), 1747-1747 2022

 

Post-transplant cyclophosphamide based anti-GVHD prophylaxis in patients with all treated in cr with ALLO-HCT from haploidentical vs HLA-mismatched unrelated donors: An ALWP …

A Nagler, M Labopin, M Arat, P Remenyi, Y Koc, D Blaise, E Angelucci, ...

Bone Marrow Transplantation 57 (SUPPL 1), 100-101 2022

 

Prediction of non-relapse mortality in patients with AML and all receiving alloSCT in first CR with post-transplantation cyclophosphamide-based GVHD prophylaxis

SJF Hermans, J Versluis, M Labopin, S Giebel, Y Van Norden, A Kulagin, ...

Bone Marrow Transplantation 57 (SUPPL 1), 16-17 2022

 

Post-transplant cyclophosphamide separates graft-versus host disease (GVHD) and graft versus leukemia (gvl) effects after HLA-matched stem-cell transplantation (sct) for AML

A Shimoni, C Peczynski, M Labopin, A Kulagin, E Meijer, J Cornelissen, ...

Bone Marrow Transplantation 57 (SUPPL 1), 104-104 2022

 

HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

F Baron, M Labopin, J Tischer, F Ciceri, AM Raiola, D Blaise, S Sica, ...

Bone Marrow Transplantation 57 (SUPPL 1), 384-385 2022

 

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute …

F Baron, M Labopin, J Tischer, F Ciceri, AM Raiola, D Blaise, S Sica, ...

Bone marrow transplantation 57 (11), 1657-1663 2022

 

Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myelogenous leukemia: a study …

A Ruggeri, JE Galimard, M Labopin, H Rafii, D Blaise, F Ciceri, ...

Transplantation and Cellular Therapy 28 (10), 710. e1-710. e10 2022

 

Correction to: Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients

H Hashem, G Bucciol, S Ozen, S Unal, IO Bozkaya, N Akarsu, M Taskinen, ...

Journal of clinical immunology 42 (7), 1580-1581 2022

 

Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT

K Raj, DJ Eikema, V Sheth, L Koster, LC de Wreede, D Blaise, ...

 

Blood cancer journal 12 (9), 140 2022

Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post …

G Battipaglia, M Labopin, D Blaise, JL Diez-Martin, A Bazarbachi, A Vitek, ...

 

Transplantation and Cellular Therapy 28 (9), 587. e1-587. e7 2022

Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood …

F Baron, M Labopin, J Tischer, F Ciceri, AM Raiola, D Blaise, S Sica, ...

American journal of hematology 97 (8), 1065-1074 2022

 

Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT

I Danylesko, C Peczynski, M Labopin, E Polge, J Tischer, D Blaise, Y Koc, ...

Bone Marrow Transplantation 57 (8), 1260-1268 2022

 

HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients≥ 55 years of age.

F Baron, M Labopin, J Tischer, F Ciceri, AM Raiola, D Blaise, S Sica, ...

American Journal of Hematology 2022

 

P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH …

A Shimoni, C Peczynski, M Labopin, E Angelucci, Y Koc, M Arat, J Tischer, ...

HemaSphere 6, 1255-1256 2022

 

Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic …

E Forcade, S Chevret, J Finke, G Ehninger, F Ayuk, D Beelen, L Koster, ...

Bone Marrow Transplantation 57 (5), 768-774 2022

 

Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and …

L Ruggeri, DJ Eikema, A Bondanza, M Noviello, A van Biezen, ...

Transplantation and Cellular Therapy 28 (4), 206. e1-206. e6 2022

 

Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the …

G Battipaglia, JE Galimard, M Labopin, AM Raiola, D Blaise, A Ruggeri, ...

Bone marrow transplantation 57 (4), 562-571 2022

 

The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML

A Shimoni, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, Z Gülbas, ...

Bone Marrow Transplantation 57 (3), 384-390 2022

 

Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation

A Nagler, M Labopin, B Dholaria, D Wu, G Choi, M Aljurf, F Ciceri, ...

Transplantation and Cellular Therapy 28 (2) 2022

 

Graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide versus cyclosporine A and methotrexate in matched sibling donor transplantation

A Nagler, M Labopin, B Dholaria, D Wu, G Choi, M Aljurf, F Ciceri, ...

Transplantation and cellular therapy 28 (2), 86. e1-86. e8 2022

 

HLA-haploidentical transplantation with PTCY in AML patients with active disease at transplantation: Better survival with bm than with PBSC in patients> 55 years

F Baron, M Labopin, J Tischer, F Ciceri, AM Raiola, D Blaise, S Sica, ...

Bone Marrow Transplantation 57 (SUPPL 1), 101-102 2022

 

Post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis in multiple myeloma patients who underwent allogeneic hematopoietic cell transplantation: first …

F Sahebi, DJ Eikema, L Koster, N Kroger, E Meijer, JA van Doesum, ...

Transplantation and cellular therapy 27 (12), 999. e1-999. e10 2021

 

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia …

J Sanz, JE Galimard, M Labopin, B Afanasyev, MI Sergeevich, ...

Journal of hematology & oncology 14 (1), 1-10 2021

 

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute …

A Nagler, M Labopin, M Houhou, M Aljurf, A Mousavi, RM Hamladji, ...

Journal of Hematology & Oncology 14 (1), 1-12 2021

 

Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in …

MA Kharfan-Dabaja, M Labopin, E Ayala, A Bazarbachi, D Blaise, Y Koc, ...

Blood 138, 3910 2021

 

Allogeneic Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia (AML) in Second Complete Remission (CR2) Transplanted from Unrelated Donors with Post …

A Nagler, M Labopin, AD Kulagin, H Labussière-Wallet, M Rovira, ...

Blood 138, 3916 2021

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

PJ Hayden, DJ Eikema, LC De Wreede, L Koster, N Kröger, H Einsele, ...

Bone Marrow Transplantation 56 (10), 2367-2381 2021

 

Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients

H Hashem, G Bucciol, S Ozen, S Unal, IO Bozkaya, N Akarsu, M Taskinen, ...

Journal of clinical immunology 41, 1633-1647 2021

 

Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of …

A Ruggeri, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, P Chiusolo, ...

Bone Marrow Transplantation 56 (8), 1842-1849 2021

 

Outcome of T‐cell–replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party …

A Nagler, M Labopin, Y Koc, E Angelucci, J Tischer, M Arat, P Pioltelli, ...

Cancer 127 (14), 2507-2514 2021

 

Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia

A Nagler, AS Kanate, M Labopin, F Ciceri, E Angelucci, Y Koc, Z Gülbas, ...

Haematologica 106 (6), 1591 2021

 

Impact of The Addition of Antithymocyte Globulin to Post-Transplant Cyclophosphamide in Haploidentical Transplantation With Peripheral Blood Compared to Post-Transplant …

G Battipaglia, M Labopin, D Blaise, JL Diez-Martin, A Bazarbachi, A Vitek, ...

Bone Marrow Transplantation 56 (SUPPL 1), 56-57 2021

 

Post-transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Versus Haploidentical Transplantation: A Retrospective Study on Behalf of The Acute …

G Battipaglia, JE Galimard, M Labopin, E Angelucci, D Blaise, A Ruggeri, ...

Bone Marrow Transplantation 56 (SUPPL 1), 171-172 2021

 

Comparison of Haploidentical Peripheral Blood Cell Transplantation Using Post-Transplant Cyclophosphamide With Double Cord Blood Transplantation in Adults With Acute Leukemia

A Ruggeri, JE Galimard, M Labopin, D Blaise, JL Diez-Martin, F Ciceri, ...

Bone Marrow Transplantation 56 (SUPPL 1), 24-25 2021

 

GVHD Prophylaxis With Post Transplantation Cyclophosphamide (PTCY) Versus Cyclosporine A/Methotrexate Post Allogeneic Transplantation (HSCT) From Matched Siblings For AML: From …

A Nagler, M Labopin, D Wu, G Choi, M Aljurf, F Ciceri, T Gedde-Dahl, ...

Bone marrow transplantation 56 (SUPPL 1), 71-72 2021

 

Non T–Cell Depleted Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Remission: A …

A Nagler, M Labopin, M Houhou, MD Aljurf, A Mousavi, RM Hamladji, ...

2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2021

Non-T-Cell Depleted Haploidentical Stem Cell Transplantation (haploHCT) with Post Transplantation Cyclophosphamide (PTCy)-the Role of Donor Kinship: From the ALWP of the EBMT

I Danylesko, C Peczynski, M Labopin, E Polge, J Tischer, D Blaise, Y Koc, ...

2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2021

 

Total body irradiation+ fludarabine compared to busulfan+ fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic …

S Giebel, M Labopin, M Sobczyk-Kruszelnicka, M Stelljes, JL Byrne, ...

Bone Marrow Transplantation 56 (2), 481-491 2021

 

Improved outcomes of haploidentical hematopoietic cell transplantation with total body irradiation-based myeloablative conditioning in acute lymphoblastic leukemia

B Dholaria, M Labopin, E Angelucci, J Tischer, M Arat, F Ciceri, Z Gülbas, ...

Transplantation and Cellular Therapy 27 (2), 171. e1-171. e8 2021

 

Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical …

G Battipaglia, M Labopin, RM Hamladji, D Blaise, P Chevallier, E Brissot, ...

Cancer 127 (2), 209-218 2021

 

Total body irradiation plus fludarabine compared to busulfan plus fludarabine as" reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with …

S Giebel, M Labopin, M Sobczyk-Kruszelnicka, M Stelljes, JL Byrne, ...

Bone Marrow Transplantation 56 (2) 2021

 

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

J Sanz, JE Galimard, M Labopin, B Afanasyev, E Angelucci, F Ciceri, ...

Journal of hematology & oncology 13 (1), 1-13 2020

 

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A …

G Battipaglia, JE Galimard, M Labopin, E Angelucci, D Blaise, A Ruggeri, ...

Blood 136, 26-27 2020

 

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia …

JA Fein, R Shouval, M Labopin, F Ciceri, E Angelucci, D Blaise, J Tischer, ...

Blood 136, 24-25 2020

 

Impact of total body irradiation‐vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia

B Dholaria, M Labopin, E Angelucci, F Ciceri, JL Diez‐Martin, B Bruno, ...

American Journal of Hematology 95 (10), 1200-1208 2020

 

A comparison of the BEAM and MITO/MEL conditioning regimens for autologous hematopoietic stem cell transplantation in Hodgkin lymphoma: An analysis of efficiency and treatment …

M Yeral, P Aytan, B Gungor, C Boga, A Unal, Y Koc, L Kaynar, ...

Clinical Lymphoma Myeloma and Leukemia 20 (10), 652-660 2020

 

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

A Nagler, B Dholaria, M Labopin, BN Savani, E Angelucci, Y Koc, M Arat, ...

Leukemia 34 (10), 2766-2775 2020

 

Unexpectedly high prevalence of low alpha-galactosidase A enzyme activity in patients with focal segmental glomerulosclerosis

NB Hasbal, FB Caglayan, T Sakaci, E Ahbap, Y Koc, M Sevinc, ZA Ucar, ...

Clinics 75 2020

 

CD34+ cell dose effects on clinical outcomes after T‐cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral …

E Maffini, M Labopin, D Blaise, F Ciceri, Z Gülbas, E Deconinck, ...

American Journal of Hematology 95 (8), 892-899 2020

 

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

PH Prata, DJ Eikema, B Afansyev, P Bosman, F Smiers, JL Diez-Martin, ...

Bone marrow transplantation 55 (6), 1050-1058 2020

 

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

MM Al Malki, D Yang, M Labopin, B Afanasyev, E Angelucci, A Bashey, ...

Blood advances 4 (9), 2073-2083 2020

 

Haploidentical transplantation with post-transplantation cyclophosphamide for T cell acute lymphoblastic leukemia: a report from the European Society for Blood and Marrow …

A Bazarbachi, M Labopin, E Angelucci, Z Gülbas, H Ozdogu, M Arat, ...

Biology of Blood and Marrow Transplantation 26 (5), 936-942 2020

 

Role of age and hematopoietic cell transplantation-specific comorbidity index in myelodysplastic patients undergoing an allotransplant: a retrospective study from the Chronic …

M Carré, R Porcher, J Finke, G Ehninger, L Koster, D Beelen, A Ganser, ...

Biology of Blood and Marrow Transplantation 26 (3), 451-457 2020

 

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma–a LWP‐EBMT study

A Bazarbachi, A Boumendil, H Finel, L Castagna, A Dominietto, D Blaise, ...

British journal of haematology 188 (5), 745-756 2020

 

Comparison of Transplant Outcomes in Patients with Acute Lymphoblastic Leukemia after Haploidentical Transplant with Post-Transplant Cyclophosphamide or Matched Unrelated Donor …

MM Al Malki, D Yang, M Labopin, B Afanasyev, E Angelucci, A Bashey, ...

Biology of Blood and Marrow Transplantation 26 (3), S58-S59 2020

 

Outcomes of Acute Myelogenous Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide: Impact of Total Body …

B Dholaria, M Labopin, E Angelucci, F Ciceri, JL Diez-Martin, B Bruno, ...

Biology of Blood and Marrow Transplantation 26 (3), S110 2020

 

Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the …

E Maffini, M Labopin, D Blaise, F Ciceri, Z Gulbas, E Deconinck, ...

Biology of Blood and Marrow Transplantation 26 (3), S287-S288 2020

 

Comparison of Matched Sibling, Unrelated and Haploidentical Donor Transplants Using Post-Transplant Cyclophosphamide in Patients with Acute Myeloid Leukemia, a Study of the …

J Sanz, JE Galimard, M Labopin, B Afanasyev, E Angelucci, F Ciceri, ...

Biology of Blood and Marrow Transplantation 26 (3), S57-S58 2020

 

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

N Shem-Tov, C Peczynski, M Labopin, M Itälä-Remes, D Blaise, ...

Leukemia 34 (1), 283-292 2020

 

Graft Failure after Unmanipulated haplo-hsct with pt-cy in Patients with Acute Myeloid Leukemia in Complete Remission, on behalf of the ALWP-EBMT

A Ruggeri, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, ...

Bone Marrow Transplantation 55 (SUPPL 1), 182-183 2020

 

Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study …

A Ruggeri, M Labopin, B Savani, A Paviglianiti, D Blaise, F Volt, F Ciceri, ...

Bone marrow transplantation 54 (12), 1987-1994 2019

 

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

S Piemontese, A Boumendil, M Labopin, C Schmid, F Ciceri, W Arcese, ...

Journal of Hematology & Oncology 12, 1-11 2019

 

Bone Marrow Versus Mobilized Peripheral Blood Stem Cells for Non T Depleted Haploidentical Transplantations with Post Transplantation Cyclophosphamide in Acute Lymphoblastic …

A Nagler, M Labopin, E Angelucci, Y Koc, M Arat, P Pioltelli, S Sica, ...

Blood 134, 589 2019

 

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia, a comparative study of the ALWP EBMT

J Sanz, JE Galimard, BV Afanasyev, E Angelucci, F Ciceri, D Blaise, ...

Blood 134, 3274 2019

 

CD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using …

E Maffini, M Labopin, D Blaise, F Ciceri, Z Gulbas, E Daguindau, ...

Blood 134, 4586 2019

 

Outcomes of total body irradiation-versus chemotherapy-based myeloablative conditioning regimen in haploidentical hematopoietic cell transplantation with post-transplant …

B Dholaria, M Labopin, E Angelucci, J Tischer, M Arat, F Ciceri, Z Gülbas, ...

Blood 134, 320 2019

 

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical …

G Battipaglia, M Labopin, RM Hamladji, D Blaise, P Chevallier, A Gerbitz, ...

Blood 134, 148 2019

 

Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a retrospective study by the EBMT chronic malignancies …

A Radujkovic, S Dietrich, HJ Blok, A Nagler, F Ayuk, J Finke, J Tischer, ...

Biology of Blood and Marrow Transplantation 25 (10), 2008-2016 2019

 

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

W Wiktor-Jedrzejczak, J Drozd-Sokolowska, DJ Eikema, J Hoek, M Potter, ...

Bone marrow transplantation 54 (9), 1391-1398 2019

 

Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study …

G Battipaglia, A Boumendil, M Labopin, F Ciceri, J Tischer, M Stelljes, ...

Bone marrow transplantation 54 (9), 1499-1510 2019

 

Post-transplant cyclophosphamide-based GVHD prophylaxis compared to standard prophylaxis in patients with lymphoma receiving HLA identical transplantation: A retrospective …

S Bramanti, A Boumendil, H Finel, I Khvedelidze, B Afanasyev, N Schmitz, ...

Bone Marrow Transplantation 54, 107-108 2019

 

Myeloablative conditioning may contribute to disease control after stem cell transplantation in blastic plasmacytoid dentric cell neoplasia

S Dietrich, H Finel, JJ Lu, A Boumendil, H Sengeloev, G Socie, ...

Bone Marrow Transplantation 54, 108-109 2019

 

Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT …

A Bazarbachi, M Labopin, E Angelucci, Z Gulbas, H Ozdogu, M Arat, ...

Bone Marrow Transplantation 54, 19-20 2019

 

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ...

Blood advances 3 (12), 1826-1836 2019

 

HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP

A Bazarbachi, A Boumendil, H Finel, L Castagna, A Dominietto, D Blaise, ...

Hematological Oncology 37, 299-300 2019

 

S114 POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF …

A Nagler, M Labopin, A Ruggeri, F Ciceri, J Sanz, E Angelucci, Y Koc, ...

HemaSphere 3 (S1), 9 2019

 

Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry …

A Bondanza, L Ruggeri, M Noviello, DJ Eikema, C Bonini, C Chabannon, ...

Bone Marrow Transplantation 54 (6), 867-876 2019

 

Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over

N Santoro, M Labopin, F Ciceri, MT Van Lint, D Nasso, D Blaise, ...

Cancer 125 (9), 1499-1506 2019

 

Graft-Versus-Leukemia Effect after Ha

plo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML-No Association with Graft-Versus-Host …

A Shimoni, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, Z Gulbas, ...

Biology of Blood and Marrow Transplantation 25 (3), S242-S243 2019

 

HLA-Matched Sibling Versus Haploidentical Hematopoietic Cell Transplantation (HCT) in Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)

A Rashidi, M Hamadani, HL Wang, J Bolanos, JW Lee, SO Ciurea, ...

Biology of Blood and Marrow Transplantation 25 (3), S59-S60 2019

 

Family mismatched allogeneic stem cell transplantation for myelofibrosis: report from the Chronic Malignancies Working Party of European Society for Blood and Marrow …

K Raj, DJ Eikema, DP McLornan, E Olavarria, HJ Blok, S Bregante, ...

Biology of Blood and Marrow Transplantation 25 (3), 522-528 2019

 

Outcomes of haploidentical transplantation in patients with relapsed multiple myeloma: an EBMT/CIBMTR report

F Sahebi, L Garderet, AS Kanate, DJ Eikema, NS Knelange, OFD Alvelo, ...

Biology of Blood and Marrow Transplantation 25 (2), 335-342 2019

 

Post-transplant cyclophosphamide vs ATG for graft-versus-host disease prophylaxis in T-replete haploidentical transplantation for acute lymphoblastic leukemia: a report of the …

A Nagler, M Labopin, A Ruggeri, F Ciceri, J Sanz, E Angelucci, Y Koc, ...

EHA Library 267315, S114 2019

 

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

K Stockerl-Goldstein 2019

 

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide

A Shimoni, M Labopin, F Lorentino, MT Van Lint, Y Koc, Z Gülbas, ...

Leukemia 33 (1), 230-239 2019

 

HLA-mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis

M Robin, R Porcher, A Ruggeri, D Blaise, C Wolschke, L Koster, ...

Biology of Blood and Marrow Transplantation 25 (1), 114-120 2019

 

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on …

A Ruggeri, M Labopin, A Bacigalupo, B Afanasyev, JJ Cornelissen, ...

Journal of hematology & oncology 11 (1), 1-10 2018

 

Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML-No Association with Graft-Versus-Host …

A Shimoni, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, Z Gülbas, ...

Blood 132, 4586 2018

 

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A …

A Bazarbachi, A Boumendil, H Finel, L Castagna, A Dominietto, D Blaise, ...

Blood, The Journal of the American Society of Hematology 132 (Supplement 1 … 2018

 

Haploidentical transplantation using high dose post-transplant cyclophosphamide for patients with aplastic anemia: the European Group for Blood and Marrow Transplantation …

PH Prata, B Afanasyev, DJ Eikema, F Smiers, C Knol, JL Diez-Martin, ...

Blood 132, 486 2018

 

Prediction of Leukemia-Free Survival Following Haploidentical Stem Cell Transplantation in Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

R Shouval, JA Fein, M Labopin, F Ciceri, E Angelucci, D Blaise, J Tischer, ...

Blood, The Journal of the American Society of Hematology 132 (Supplement 1 … 2018

 

Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party study

A Paviglianiti, KT Maio, V Rocha, E Gehlkopf, N Milpied, A Esquirol, ...

Biology of Blood and Marrow Transplantation 24 (11), 2265-2270 2018

 

Stem cell transplantation from unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, comparative study from Eurocord and …

A Ruggeri, M Labopin, B Savani, D Blaise, F Volt, F Ciceri, A Bacigalupo, ...

Bone Marrow Transplantation 53, 33-34 2018

 

External validation of scores predicting non-relapse mortality in patients with myelodysplastic syndrome: a study from MDS subcommittee of the CMWP EBMT

M Carre, R Porcher, J Finke, G Ehninger, L Koster, D Beelen, A Ganser, ...

Bone Marrow Transplantation 53, 664-666 2018

 

The outcome of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma. An EBMT/CIBMTR Report

F Sahebi, L Garderet, A Kanate, DJ Eikema, NS Knelange, OFD Alvelo, ...

Bone Marrow Transplantation 53, 110-111 2018

 

Leukemia relapse following unmanipulated haploidentical transplantation: a risk-factors analysis of on behalf of the Acute Leukemia Working Party of the EBMT

S Piemontese, A Boumendil, M Labopin, C Schmid, F Ciceri, W Arcese, ...

Bone Marrow Transplantation 53, 82-83 2018

 

Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation …

Z Li, M Labopin, F Ciceri, D Blaise, J Tischer, G Ehninger, MT Van Lint, ...

American journal of hematology 93 (6), 769-777 2018

 

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working …

SP Robinson, A Boumendil, H Finel, KS Peggs, P Chevallier, J Sierra, ...

Bone marrow transplantation 53 (5), 617-624 2018

 

Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide

A Ruggeri, M Labopin, A Bacigalupo, Z Gülbas, Y Koc, D Blaise, B Bruno, ...

Cancer 124 (7), 1428-1437 2018

 

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the …

S Cesaro, R Crocchiolo, G Tridello, N Knelange, MT Van Lint, Y Koc, ...

Bone marrow transplantation 53 (4), 422-430 2018

 

Haploidentical Transplantation Outcomes for Secondary Acute Myeloid Leukemia—on Behalf of the ALWP of the EBMT

Z Li, M Labopin, BN Savani, F Ciceri, D Blaise, J Tischer, G Ehninger, ...

Biology of Blood and Marrow Transplantation 24 (3), S292-S293 2018

 

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

G van Gorkom, M van Gelder, DJ Eikema, HJ Blok, MT Van Lint, Y Koc, ...

Bone Marrow Transplantation 53 (3), 255-263 2018

 

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation

J Canaani, BN Savani, M Labopin, XJ Huang, F Ciceri, W Arcese, Y Koc, ...

American journal of hematology 93 (2), 246-253 2018

 

Comparative outcomes for matched and mismatched (haplo) family donors for Myelodysplastic syndromes: Results from the EBMT Chronic Leukaemia Working Party

K Raj, DJ Eikema, L Koster, MT Van Lint, D Blaise, A Nagler, D Beelen, ...

Bone Marrow Transplantation 53, 137-138 2018

 

The differential diagnostic role of PET-CT in sarcoidosis and lymphoma

AB Kargi, H Süslü, Ç Ünsal, OF Boztepe, Y Koç

Current Thoracic Surgery 3 (1) 2018

 

Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study

A Paviglianiti, K Tozatto-Maio, V Rocha, E Gehlkopf, N Milpied, A Esquirol, ...

Blood 130, 3318 2017

 

KIR-Ligand Mismatching Is Associated with Inferior Survival in Patients with Acute Leukemia Following T-Cell Replete Peripheral-Blood Stem Cell Haplo-Identical Transplantation …

A Shimoni, M Labopin, F Lorentino, MT Van Lint, K Yener, Z Gülbas, ...

Blood 130, 3302 2017

 

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor …

A Ruggeri, M Labopin, BV Afanasyev, JJ Cornelissen, A Elmaagacli, ...

Blood 130, 215 2017

 

Haplo-Identical Stem Cell Transplantation for Patients with Multiple Myeloma Who Relapsed after Autografting. a Study from the Cmwp of EBMT

N Kroeger, DJ Eikema, NS Knelange, Y Koc, JM Moraleda, P Dreger, ...

Blood 130, 2046 2017

 

Donor age determines outcome in acute leukemia patients undergoing haploidentical hematopoietic cell transplantation

J Canaani, BN Savani, M Labopin, XJ Huang, F Ciceri, W Arcese, Y Koc, ...

Blood 130, 850 2017

 

Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of …

M Carre, R Porcher, J Finke, G Ehninger, DW Beelen, L Koster, A Ganser, ...

Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2028 … 2017

 

An EBMT Analysis of Matched Sibling, Mismatched Family or Matched Unrelated Donors for Allogeneic Stem Cell Transplants in MDS

K Raj, DJ Eikema, G Ehninger, C Wolschke, L Koster, G Socié, J Finke, ...

Blood 130 (Supplement 1), 4593-4593 2017

 

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

N Santoro, A Ruggeri, M Labopin, A Bacigalupo, F Ciceri, Z Gülbaş, ...

Journal of hematology & oncology 10, 1-11 2017

 

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

N Santoro, A Ruggeri, M Labopin, A Bacigalupo, F Ciceri, Z Gülbaş, ...

Journal of hematology & oncology 10, 1-11 2017

 

Haploidentical transplant in patients with myelodysplastic syndrome

M Robin, R Porcher, F Ciceri, MT van Lint, S Santarone, G Ehninger, ...

Blood Advances 1 (22), 1876-1883 2017

 

KIR-ligand mismatching is associated with inferior survival in patients with acute leukemia following T-cell replete haplo-identical transplantation with post-transplant …

A Shimoni, M Labopin, F Lorentino, MT van Lint, Y Koc, Z ulbas, ...

Bone Marrow Transplantation 52, S39-S39 2017

 

Anti GvHD prophylaxis shape the effect of HLA mismatches on the unshared haplotype in T-cell repleted haploidentical stem cell transplantation: a study from the Acute Leukemia …

F Lorentino, M Labopin, K Fleishhauer, F Ciceri, C Mueller, A Ruggeri, ...

Bone Marrow Transplantation 52, S36-S36 2017

 

Long-term follow-up of patients undergoing reduced intensity allogeneic stem cell transplantation for mantle cell lymphoma. a study of the Lymphoma Working Party-EBMT

S Robinson, A Boumendil, H Finel, K Thomson, P Chevallier, J Sierra, ...

Bone Marrow Transplantation 52, S92-S93 2017

 

A risk-factor analysis for overall survival in patients with acute leukemia that relapse following T-replete haploidentical transplantation: On behalf of the acute leukemia …

S Piemontese, M Labopin, F Ciceri, C Schmid, A Ruggeri, W Arcese, ...

Bone Marrow Transplantation 52, S387-S387 2017

 

Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the Acute Leukemia …

J Canaani, BN Savani, M Labopin, X Huang, F Ciceri, W Arcese, J Tischer, ...

haematologica 102 (6), 1066 2017

 

GVHD PROPHYLAXIS MODULATES THE INFLUENCE OF HLA MISMATCHES ON THE UNSHARED HAPLOTYPE ON THE OUTCOMES AFTER T-CELL REPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION

F Lorentino, M Labopin, K Fleischhauer, F Ciceri, CR Mueller, A Ruggeri, ...

HLA 89 (6), 361-361 2017

 

The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis

F Lorentino, M Labopin, K Fleischhauer, F Ciceri, CR Mueller, A Ruggeri, ...

Blood Advances 1 (11), 669-680 2017

 

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant

A Ruggeri, Y Sun, M Labopin, A Bacigalupo, F Lorentino, W Arcese, ...

haematologica 102 (2), 401 2017

 

Reduced intensity allogeneic stem cell transplantation for mantle cell lymphoma: long term outcomes.

S Robinson, A Boumendil, H Finel, K Thomson, P Chevallier, J Sierra, ...

Bone Marrow Transplantation, 52 S17–S115 2017

 

Family mismatched allogeneic stem cell transplantationfor myelofibrosis: Report from the chronic malignancies working party of EBMT

K Raj, E Olavarria, DJ Eikema, HJ Blok, S Bregante, F Ciceri, J Passweg, ...

Bone Marrow Transplantation 52 (Supplement: 1), S182-S183 2017

 

Post transplant cyclophosphamide (PT-Cy) in association to standard GVHD prophylaxis in sibling and unrelated allogeneic stem cell transplantation (HSCT) for patients with …

A Ruggeri, M Labopin, B Afanasyev, J Cornelissen, B Glass, D Blaise, ...

Bone Marrow Transplantation 52 (S1), 82-82 2017

 

Impact of conditioning regimen on outcomes of T-replete haplo-identical transplantation for patients over 45 years-old with AML: a study on behalf of the Acute Leukemia Working …

D Nasso, M Labopin, A Ruggeri, F Ciceri, MT Van Lint, W Arcese, ...

Haematologica, 132-132 2017

 

Comparable Outcomes Using A CMV-Matched or A Mismatched Donor for CMV Plus Patients Undergoing T-Replete Haplo-HSCT with PT-Cy for Acute Leukemia: A Study from IDWP and ALWP of …

S Cesaro, R Crocchiolo, G Tridello, N Knelange, MT Van Lint, Y Koc, ... 2017

 

ABO mismatching and haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia: a report from the ALWP of the EBMT

BN Savani, M Labopin, J Canaani, XJ Huang, W Arcese, J Tischer, Y Koc, ... 2017

 

Haplo-identical transplantation (haplo-HSCT) in patients with myelodysplastic syndrome (MDS): a report from the European Society of Blood and Marrow Transplantation

M Robin, R Porcher, L Koster, F Ciceri, MT van Lint, P Di Bartolomeo, ...

Bone Marrow Transplantation 52, S96-S97 2017

 

Mother donors improve outcomes after HLA haploidentical hematopoietic transplantation: a retrospective study by the Cell Therapy and Immunobiology Working Party of the EBMT

A Velardi, L Ruggeri, D Ziagkos, A van Biezen, M Merluzzi, A Bondanza, ...

Blood 128 (22), 3472 2016

 

Use of bone marrow or peripheral blood stem cell grafts in non T cell depleted haploidentical transplants using post-transplant cyclophosphamide, an ALWP-EBMT analysis

A Ruggeri, M Labopin, A Bacigalupo, Z Gülbas, Y Koc, D Blaise, B Bruno, ...

Blood 128 (22), 1165 2016

 

Outcomes of mismatched related allogeneic stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party …

G van Gorkom, M van Gelder, D Ziagkos, HJ Blok, MT van Lint, Y Koc, ...

Blood, The Journal of the American Society of Hematology 128 (22), 3504-3504 2016

 

Allogeneic genetically modified T Cells (HSV-TK) as adjunctive treatment in haploidentical hematopoietic stem-cell transplantation (haplo-HSCT) of adult patients with high-risk …

M Mohty, M Labopin, A Velardi, MT van Lint, D Bunjes, B Bruno, ...

Blood 128 (22), 672 2016

 

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

MT Rubio, BN Savani, M Labopin, S Piemontese, E Polge, F Ciceri, ...

Journal of hematology & oncology 9, 1-12 2016

 

ABO mismatch and haploidentical hematopoietic stem cell transplantation in AML-a report from the ALWP of the EBMT

BN Savani, L Myriam, C Jonathan, C Fabio, A William, T Johanna, ...

Bone Marrow Transplantation, 1-2 2016

 

Mother donors improve outcomes after HLA haploidentical T cell-depleted hematopoietic transplantation: A Retrospective Study by the Cell Therapy and Immunobiology Working Party …

A Velardi, D Ziagkos, A Biezen, L Ruggeri, M Merluzzi, A Bondanza, ...

Bone Marrow Transplantation 51, S150-S150 2016

Impact of graft versus host disease prophylaxis on out

comes of unmanipulated haploidentical stem cell transplantation: post-transplant cyclophosphamide versus antithymocyte …

A Ruggeri, Y Sun, M Labopin, F Lorentino, A Bacigalupo, W Arcese, ...

Bone Marrow Transplantation 51, S27-S27 2016

 

HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia …

F Lorentino, F Ciceri, M Labopin, A Ruggeri, Z Guelbas, Y Koc, W Arcese, ...

Bone Marrow Transplantation, S28-S29 2016

 

Refined graft-versus-host disease-free/relapse-free survival-a novel outcome endpoint for haploidentical transplantation in adults with acute leukemia: on behalf of ALWP-EBMT

S Sestili, A Ruggeri, M Labopin, MT Van Lint, A Velardi, W Arcese, G Zafer, ...

Bone Marrow Transplantation 51 2016

 

Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute …

E Brissot, M Labopin, F Ciceri, M Bornhäuser, J Tischer, M Stelljes, Y Koc, ...

Bone Marrow Transplantation, S65-S65 2016

 

Comparison of outcome after haplo-identical, HLA-mismatched unrelated donor and unrelated cord blood transplantation in patients with myelodysplastic syndrome (MDS) and …

M Robin, R Porcher, MT Van Lint, F Ciceri, J Tisher, J Sanz, U Platzbecker, ...

Bone Marrow Transplantation, S73-S73 2016

 

Allogeneic Stem Cell Transplantation for Elderly Patients with Intermediate-Risk Cytogenetic Acute Myeloid Leukemia and Internal Tandem Duplication of FLT3 (FLT3-ITD); A Study …

X Poiré, M Labopin, JR Passweg, C Craddock, D Blaise, J Cornelissen, ...

Blood 126 (23), 4364 2015

 

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the …

A Bondanza, L Ruggeri, D Ziagkos, C Bonini, C Chabannon, N Bootsman, ...

Blood 126 (23), 1929 2015

 

Results of Allogeneic Transplantation As First Line Rescue Therapy in Patients with Multiple Myeloma Relapsing to a Prior Autograft: Role of Conditioning Regimen

JA Perez-Simon, FJ Marquez-Malaver, C Knol, S Iacobelli, D Blaise, ...

Blood 126 (23), 4373 2015

 

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the …

A Bondanza, L Ruggeri, D Ziagkos, C Bonini, C Chabannon, N Bootsman, ...

Blood 126 (23), 1929 2015

 

HLA disparities impact on outcomes after unmanipulated haploidentical hematopoietic stem cells transplantation (HaploSCT) in acute leukemia: a study from the Acute Leukemia …

F Lorentino, F Ciceri, M Labopin, Z Gülbas, Y Koc, W Arcese, B Bruno, ...

Blood 126 (23), 399 2015

 

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the …

A Bondanza, L Ruggeri, D Ziagkos, C Bonini, C Chabannon, N Bootsman, ...

Blood 126 (23), 1929 2015

 

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report

M Sevinc, T Basturk, T Sahutoglu, T Sakaci, Y Koc, E Ahbap, C Akgol, ...

Journal of Medical Case Reports 9, 1-5 2015

 

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

A Ruggeri, M Labopin, G Sanz, S Piemontese, W Arcese, A Bacigalupo, ...

Leukemia 29 (9), 1891-1900 2015

 

AUTOLOGOUS STEM CELL TRANSPLANTATION WITH HIGH-DOSE MITOXANTRONE AND MELPHALAN IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA: LONG-TERM SURVIVAL AND TOXICITY DATA

B Gungor, M Yeral, M Adam, C Unsal, C Boga, H Ozdogu, Y Koc

Haematologica 100, 280-280 2015

 

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

S Piemontese, F Ciceri, M Labopin, A Bacigalupo, H Huang, S Santarone, ...

Leukemia 29 (5), 1069-1075 2015

 

Unmanipulated haploidentical stem cell transplantation after reduced intensity or ablative conditioning regimen for the treatment of acute leukemia-a report from the acute …

MT Rubio, BN Savani, M Labopin, E Polge, F Ciceri, A Bacigalupo, ...

Bone Marrow Transplantation 50, S24-S25 2015

 

Allogeneic Stem-Cell Transplantation In AML with Myeloablative compared to Reduced Intensity Conditioning: 10 Years Later. A report on behalf of the ALWP of EBMT

A Shimoni, M Labopin, F Ciceri, A Bacigalupo, W Arcese, Y Koc, D Beelen, ...

Bone Marrow Transplantation 50, S11-S11 2015

 

Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology working party-EBMT; ALWP-EBMT study. Comparison of outcomes after unrelated cord blood and unmanipulated …

A Ruggeri, M Labopin, G Sanz, S Piemontese, W Arcese, A Bacigalupo, ...

Leukemia 29 (9), 1891-1900 2015

 

Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT). A survey on unmanipulated haploidentical hematopoietic stem cell …

S Piemontese, F Ciceri, M Labopin, A Bacigalupo, H Huang, S Santarone, ...

Leukemia 29 (5), 1069-1075 2015

 

Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study

A Ruggeri, M Labopin, GF Sanz, S Piemontese, W Arcese, A Bacigalupo, ...

Blood 124 (21), 1227 2014

 

UNMANIPULATED GRAFT HAPLOINDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION (HAPLO-SCT) IN ACUTE LEUKEMIA: A LONG-TERM FOLLOW-UP SURVEY ON BEHALF OF THE ACUTE LEUKEMIA WORKING …

S Piemontese, F Ciceri, M Labopin, NC Gorin, H Huang, P Di Bartolomeo, ...

Bone Marrow Transplantation 49, S70-S71 2014

 

COMPARATIVE STUDY OF UNRELATED CORD BLOOD AND NON T-CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA

A Ruggeri, L Myriam, S Piemontese, W Arcese, A Bacigalupo, DI Blaise, ...

Bone Marrow Transplantation 49, S57-S58 2014

 

COMPARATIVE STUDY OF UNRELATED CORD BLOOD AND NON T-CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA

A Ruggeri, L Myriam, S Piemontese, W Arcese, A Bacigalupo, DI Blaise, ...

Bone Marrow Transplantation 49, S57-S58 2014

 

A Case of Atypical Hemolytic Uremic Syndrome Superimposed on Behcet’s Disease

T Sakaci, E Ahbap, M Toprak, M Sevinc, T Basturk, Y Koc, S Akpinar, ...

International Journal of Medical and Pharmaceutical Case Reports 1 (1), 17-23 2014

EBMT PROSPECTIVE NON-INTERVENTIONAL STUDY ON ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN T-PROLYMPHOCYTIC LEUKEMIA (T-PLL). PRELIMINARY ANALYSIS OF 43 PATIENTS

W Wiktor-Jedrzejczak, S Iacobelli, J Hoek, JM Drozd-Sokolowska, ...

Nature Publishing Group 2014

 

Unmanipulated Graft Haploindentical Allogeneic Stem Cell Transplantation (Haplo-SCT) In Acute Leukemia: A Long-Term Follow-Up Survey On Behalf Of The Acute Leukemia Working …

S Piemontese, F Ciceri, M Labopin, NC Gorin, H Huang, P Di Bartolomeo, ...

Blood 122 (21), 2105 2013

 

EBMT Prospective Non-Interventional Study On Allogeneic Hematopoietic Stem Cell Transplantation In T-Prolymphocytic Leukemia (T-PLL). Preliminary Analysis Of 43 Patients

WW Jedrzejczak, S Iacobelli, JDC Hoek, JE Drozd-Sokolowska, M Potter, ...

Blood 122 (21), 3336 2013

 

Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease

A Unsal, S Kose Budak, Y Koc, T Basturk, T Sakaci, E Ahbap, A Sinangil

Kidney and Blood Pressure Research 36 (1), 55-64 2013

 

Mesenchymal stem cells in the management of therapy-resistant graft-versus-host disease: Turkish experience

G Sezgin, M Pehlivan, G Sucak, Y Koç, P Topcuoglu, A Unal, A Tanyeli, ...

Bone Marrow Transplantation 48, S83-S83 2013

 

Mantle Cell Lymphoma: Decision Making for Transplant

Y Koc, T Demirer

New Advances in Stem Cell Transplantation  Intech Open Access Publisher 2012

 

High complete remission rate and durable remissions achieved with rational use of autologous stem‐cell transplantation, thalidomide maintenance, and non‐myeloablative …

B Oyan, Y Koc, E Ozdemir, A Kars, A Turker, G Tekuzman, E Kansu

Clinical transplantation 23 (6), 839-847 2009

 

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

S Cesaro, HH Hirsch, M Faraci, J Owoc-Lempach, A Beltrame, A Tendas, ...

Clinical infectious diseases 49 (2), 233-240 2009

 

Validation of FDG-PET/CT in evaluation of early remission in patients with refractory lymphoma after treatment with high dose chemotherapy (HDT) and autologous stem cell …

N Selcuk, G Civi, H Selcuk, T Toklu, Y Koc

Journal of Nuclear Medicine 49 (supplement 1), 338P-338P 2008

 

A retrospective EBMT survey on the use of cidofovir for BK-related haemorrhagic cystitis after allogeneic haematopoietic stem cell transplant

S Cesaro, Y Koc, A Tendas, M Caniglia, A Beltrame, N Khanna, M Faraci, ...

EBMT 2008 41 (Suppl. 1), 60-60 2008

 

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory …

Y Urun, H Abali, B Oksuzoglu, B Budakoglu, N Yildirim, T Guler, G Ozet, ...

Blood 110 (11), 4438 2007

 

Bortezomib, Dexamethasone and Concomitant or Sequential Thalidomide (VTD): An Effective Combination for Relapsed/Refractory Multiple Myeloma Failing Thalidomide and Dexamethasone.

E Ozdemir, Y Koc, A Kars, A Turker, G Tekuzman, E Kansu

Blood 110 (11), 4810 2007

 

Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma at Yeditepe University Hospital

S Yüce, G Kalayci, S Aktas, D Aydin, B Oyan, Y Koc

Artificial Organs 31 (11) 2007

 

Hemorrhagic cystitis due to viral infection following hematopoietic stem cell transplantation

C Obek, T Kocagoz, S Aktas, F Yencilek, BO Uluc, Y Koc

Mary Ann Liebert Inc 2007

 

Splenectomy status of the patient may have impact on response to donor lymphocyte infusions

D Uckan-Cetinkaya, S Unal, M Cetin, Ü Sarikabadayi, D Aktaş, Y Koç

Leukemia 21 (9), 2049-2050 2007

 

Is there a predictive role for GA-67 scintigraphy in patients with lymphoma undergoing autologous stem cell transplantation?

P Kiratli, B Erbas, E Ozdemir, Y Koc

Ferrata  Storti Foundation 2007

 

The autologous hematopoietic stem cell transplantation in adult patients with lymphoma: Turkish Bone Marrow Transplantation Registry results

F Arpaci, S Ataergin, G Gürman, S Çagirgan

Turkish Journal of Cancer 37 (2), 45 2007

 

Ga-67 scintigraphy in lymphoma patients undergoing bone marrow transplantation

PÖ Kiratli, B Erbas, E Özdemir, Y Koç

Turkish Journal of Cancer 37 (2), 54 2007

 

Possible BK virus outbreak in haematopoietic stem cell transplant recipients: P638

M Sonmezoglu, S Yirmibescik, C Obek, D Colak, T Kocagoz, Y Koc

Clinical Microbiology & Infection 13 2007

 

256: Hematopoietic stem cell transplantation for hematological diseases at Yeditepe University Hospital

S Yirmibescik, V Senkal, G Kalayci, S Aktas, D Aydin, M Sonmezoglu, ...

Biology of Blood and Marrow Transplantation 13 (2), 94 2007

Bacillus Circulans Paracardiac Infection in Non-Hodgkin Lymphoma–

Y Gurol, Z Kipritci, NA Selcuk, Y Koc, S Kocagoz

Prague medical report 108 (1), 19-22 2007

 

P638 Possible BK virus outbreak in haematopoietic stem cell transplant recipients

M Sonmezoglu, S Yirmibescik, C Obek, D Colak, T Kocagoz, Y Koc

International Journal of Antimicrobial Agents, S150 2007

 

Nephrologic complications in stem cell transplantation

U Yakupoglu, BO Uluc, Y Koc

Oxford Univeristy Press 2007

 

Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis.

E Ozdemir, Y Koc, E Kansu

American journal of hematology 81 (6), 474-474 2006

 

Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis

B Oyan, Y Koc, S Emri, E Kansu

Medical Oncology 23, 125-129 2006

 

Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?

B Oyan, Y Koc

Annals of oncology 17 (2), 349-350 2006

 

Phase III trial of valacyclovir for the prevention of shingles after hematopoietic stem cell transplantation

AK Klein, J DesJardins, Y Koc, KB Miller, DS Schenkein, KS Sprague, ...

Biology of Blood and Marrow Transplantation 12 (2), 138-139 2006

 

Primer kutanöz lenfoma: retrospektif değerlendirme

A Ferahbaş, Y Ulaş, S Utaş, B Eser, Ö Canöz, İ Sarı, O Kontaş, M Çetin, ...

Erciyes Tıp Dergisi 2, 77-81 2006

 

High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma

B Oyan, Y Koc, E Ozdemir, A Kars, A Turker, G Tekuzman, E Kansu

Leukemia & lymphoma 47 (8), 1545-1552 2006

 

Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell …

B Oyan, Y Koc, E Ozdemir, A Kars, A Turker, G Tekuzman, E Kansu

Biology of Blood and Marrow Transplantation 11 (9), 688-697 2005

 

IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation

H Abali, B Oyan, Y Koc, A Kars, I Barista, A Uner, A Turker, F Demirkazik, ...

American journal of clinical oncology 28 (3), 264-269 2005

 

High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL

B Oyan, Y Koc, E Ozdemir, E Kansu

Bone Marrow Transplantation 35, S385-S385 2005

 

Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle …

B Oyan, Y Koc, E Kansu

International journal of hematology 81, 155-158 2005

 

Predictive Value of Ga-67 Scintigraphy in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation

P Kiratli, Y Koc, B Erbas, E Ozdemir

Europen Journal of Nuclear Medicine and Molecular Imaging 32 2005

 

Nonmyeloablative Allogeneic Stem Cell Transplantation: Hacettepe University Institute of Oncology Experience.

Y Koc, E Ozdemir, B Oyan, E Kansu

Blood, The Journal of the American Society of Hematology 104 (11), 5155-5155 2004

 

High-Dose Sequential Chemotherapy (HDSC) in Support of Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL) and Non-Hodgkin …

B Oyan, Y Koc, E Ozdemir, E Kansu

Blood 104 (11), 5231 2004

 

Successful allogeneic marrow transplantation from donors with hematologic malignancies

Y Koç, B Oyan, MS Akhtar, DP Schenkein, KB Miller

Turkish Journal of Cancer 34 (3), 118 2004

 

A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia

Y Koc, B Oyan, A Kars, G Tekuzman, H Canpinar, E Kansu

Hematological Oncology 22 (2), 43-53 2004

 

Hodgkin dışı lenfomalı hastaların klinik özelliklerinin ve tedavi sonuçlarının değerlendirilmesi

H Karaoğlu, M Gümüş, H Sargın, Y Koç, Ş Güler, A Topal, ...

Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi 15 (1), 8-10 2004

 

Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)

B Oyan Uluç, G Tekuzman, İ Barışta, Y Ozisik, A Turker, Ş Yalçın, ...

Annals of Oncology 15 2004

 

Achieving high remission rate with use of autologous HSCT, thalidomide maintenance and non-myeloablative allogeneic HSCT in patients with multiple myeloma.

B Oyan, Y Koc, A Kars, A Turker, G Tekuzman, E Kansu 2003

 

Pankreas Karsinomlu Olguların Değerlendirilmesi

Y Koç, H Sargın, C Gemici, F Bölükbaşı, M Gümüş, M Tekçe, T Salepçi, ... 2003

 

Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma

GB Sentürk, S Sahin

Turkish Journal of Cancer 33 (1), 23 2003

 

Akut Myeloid Lösemide Transplantasyon

B Oyan, Y Koç

Türkiye Klinikleri Tıp Bilimleri 1 (1) 2003

 

Chronic graft-versus-host disease after allogeneic stem cell transplantation

E Kansu, Y Koc, KM Sullivan

Turkish Journal of Cancer 33 (1), 9 2003

 

Hematopoietic stem cell transplantation in hematologic malignancies and solid tumors: Hacettepe University Institute of Oncology experience

B Oyan, Y Koç, A Kars, A Türker

Turkish Journal of Cancer 33 (1), 27 2003

 

IIVP salvage regimen induces high response rates in patients with relapsed FED or NHL prior to autologous HSCT.

H Abali, Y Koc, B Oyan, F Tekin, G Tekuzman, E Kansu 2002

 

Successful salvage with high-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with Rituximab in patients with primary refractory mantle cell …

B Oyan, Y Koc, F Tekin, E Kansu 2002

High-dose sequential chemotherapy in refractory

Hodgkin's and non-Hodgkin's lymphoma.

B Oyan, Y Koc, E Kansu

Blood 100 (11), 471B-471B 2002

 

Problems encountered during IFN-alfa therapy following autologous stem cell transplantation: a preliminary report

S Kav, Y Koc, E Kansu

Bone Marrow Transplantation 29, S261-S262 2002

 

Factors for chronic GvHD after allogeneic peripheral blood stem cell transplants (allo-PBSCT) in patients with acute leukemia (AL)

V Rocha, M Labopin, Y Koc, J Finke, A Gratwohl, A Fassas, A Schwaren, ...

Bone Marrow Transplantation 29, S73-S74 2002

 

Risk factors for chronic GvHD after allogeneic peripheral blood stem cell transplants (allo-PBSCT) in patients with acute leukemia (AL).

V Rocha, M Labopin, Y Koc, J Finke, A Gratwohl, A Fassas, AP Schwarer, ...

Blood 98 (11), 397A-398A 2001

 

IIVP regimen for salvage therapy in patients with relapsed lymphoma prior to autologous stem cell transplantation.

H Abali, A Karaoglu, G Tekuzman, Y Koc, E Kansu

Blood 98 (11), 389B-389B 2001

 

Basic concepts in autologous peripheral blood stem cell transplantation: an educational course for nurses

S Kav, Y Koc, N Ecioglu, E Kansu

Bone Marrow Transplantation 27, S393-S393 2001

 

Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor

DP Schenkein, Y Koc, T Alcindor, EA Stadtmauer, KB Miller, BW Cooper, ...

Biology of Blood and Marrow Transplantation 6 (4), 448-455 2000

 

Response to Gratwohl et al

K Miller, D Schenkein, G Jabro, Y Koc, T Boyle, J Ravalese, D Wazer

Biology of Blood and Marrow Transplantation 6 (2A), 213-213 2000

 

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome

Y Koc, KB Miller, DP Schenkein, J Griffith, M Akhtar, J DesJardin, ...

Biology of Blood and Marrow Transplantation 6 (1), 44-49 2000

 

Second allogeneic bone marrow transplant after relapse of hematologic malignancies following first autologous or allogeneic bone marrow transplant.

T Roberts, Y Koc, K Sprague, H Grodman, D Mogavero, E Berkman, ...

Blood 94 (10), 380B-380B 1999

 

A randomized trial of 2 different priming methods for stem cell mobilization in patients with relapsed Hodgkin's disease and non-Hodgkin's lymphoma.

DP Schenkein, CE O'Connor, JA Morelli, E Berkman, JK Erban, ...

Blood 94 (10), 326A-327A 1999

 

Outcome of patient's with primary refractory non-Hodgkins lymphoma (NHL) and Hodgkin's disease (HD) treated with allogeneic or autologous bone marrow transplant (BMT).

T Roberts, Y Koc, K Sprague, H Grodman, E Berkman, D Schenkein, ...

Blood 94 (10), 168A-169A 1999

 

Mycophenolate mofetil (MMF) for the treatment of chronic graft versus host disease (CGVHD) of the liver.

T Roberts, Y Koc, K Sprague, H Grodman, E Berkman, D Schenkein, ...

Blood 94 (10), 159A-159A 1999

 

Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation

G Jabro, Y Koc, T Boyle, DP Schenkein, J Ravalese, D Wazer, KB Miller

Biology of Blood and Marrow Transplantation 5 (3), 173-179 1999

 

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation

Y Koc, KB Miller, DP Schenkein, P Daoust, K Sprague, E Berkman

Cancer: Interdisciplinary International Journal of the American Cancer … 1999

 

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk

EA Engels, CA Ellis, SE Supran, CH Schmid, M Barza, DP Schenkein, ...

Clinical infectious diseases 28 (2), 256-266 1999

 

Schenkein dP, daoust P, Sprague K, Berkman e. extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation

Y Koc, KB Miller

Cancer 85, 608-15 1999

 

Therapy of diffuse aggressive lymphomas

Y Koc, DP Schenkein

Diagnostic and Therapeutic Advances in Hematologic Malignancies, 47-73 1999

 

A-randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in previously untreated patients with acute myeloblastic leukemia.

Y Koc, E Kansu, A Kars, G Akpek, G Tekuzman, D Firat

Blood 92 (10), 217B-217B 1998

 

High-dose chemoradiotherapy and peripheral stem cell rescue for primary resistant or recurrent myeloma: Long-term follow-up of phase I-II study.

DP Schenkein, Y Koc, T Alcindor, EA Stadtmauer, KB Miller, HM Lazarus

Blood 92 (10), 663A-663A 1998

 

Treatment of relapsed/refractory or secondary acute leukemias with allogeneic bone marrow transplantation.

Y Koc, K Sprague, DP Schenkein, E Berkman, KB Miller

Blood 92 (10), 351B-351B 1998

 

Ganciclovir administration for cytomegalovirus infection prophylaxis delays onset of varicella zoster virus reactivation in allogeneic bone marrow transplant recipients.

Y Koc, K Miller, DP Schenkein, J DesJardin, DR Snydman

Blood 92 (10), 280A-281A 1998

 

Vancomycin-resistant enterococcal infections in bone marrow transplant recipients

Y Koc, DR Snydman, DS Schenkein, KB Miller

Bone marrow transplantation 22 (2), 207-209 1998

 

Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells

A Urbano, Y Koc, FM Foss

Leukemia 12 (6), 930-936 1998

 

Current management of diffuse aggressive lymphomas: Role of dose-intensive chemotherapy and peripheral stem cell/marrow transplantation-II

Y Koç

Turkish Journal of Cancer 28 (4), 151-165 1998

 

Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies

Y Koc, G Akpek, E Kansu, A Kars, G Tekuzman, E Baltali, N Guler, ...

Cancer investigation 16 (6), 355-365 1998

 

Comparison of standard and short course methotrexate (MTX) in combination with adjusted dose continuous infusion cyclosporin-A (CSA) to prevent acute graft versus host disease …

Y Koc, KB Miller, DP Schenkein, K Sprague, E Berkman

Blood 90 (10), 4413-4413 1997

 

The role of splenic irradiation (XRT) prior to bone marrow transplantation (BMT) for chronic myeloid leukemia (CML).

G Jabro, Y Koc, K Miller, T Boyle, J Ravalese, D Schenkein, K Sprague, ...

Blood 90 (10), 1669-1669 1997

 

Varicella zoster virus infections (VZV) following allogeneic bone marrow transplantation (BMT): Frequency, risk factors, clinical outcome and antiviral prophylaxis.

Y Koc, K Miller, D Schenkein, K Sprague, E Berkman, J Desjardin, ...

Blood 90 (10), 2420-2420 1997

 

Management of acute myeloid leukemia and bone marrow transplantation in the elderly

Y Koç, KB Miller

Turkish Journal of Cancer 27 (4), 143-160 1997

 

Augmentation of vincristine cytotoxicity by megestrol acetate

S Tansan, Y Koç, H Aydin, G Urbano, R McCaffrey

Cancer chemotherapy and pharmacology 39, 333-340 1997

 

Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells.

Y Koc, AG Urbano, EB Sweeney, R McCaffrey

Leukemia 10 (6), 1019-1024 1996

 

Urinary neopterin levels as an indicator of disease activation in Behçet’s disease

Z Altindağ, G Şahin, G Akpek, A Işimer, E Kansu, S Duru

Pteridines 6 (2), 79-83 1995

 

2', 3'-Dideoxyadenosine killing of TdT-positive cells is due to a trace contaminant.

Y Koç, R McCaffrey

Leukemia 9 (1), 53-57 1995

 

Cordycepin-induced apoptotic cell death in TDT positive leukemia/lymphoma cells is associated with nitric-oxide formation

Y Koc, T Cotter, R McCaffrey

Blood 84 (10), A285-A285 1994

 

Arginine butyrate induces apoptosis in selected hematopoietic tumor cell lines

Y Koc, R McCaffrey, F Foss

Blood 84 (10), A141-A141 1994

 

Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon

S Tansan, S Emri, T Selçuk, Y Koç, P Hesketh, T Heeren, RP McCaffrey, ...

Oncology 51 (4), 348-351 1994

 

Combined antiproliferative effects of taxol and arginine butyrate on human mesothelioma cells

S Emri, Y Koç, MC O'brien, D Sanders, S Tansan, F Foss

Lung Cancer 11, 191 1994

 

Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.

FM Foss, Y Koc, MA Stetler-Stevenson, DT Nguyen, MC O'Brien, R Turner, ...

Journal of clinical oncology 12 (2), 326-335 1994

 

Cydycepin activates an apoptotic cascade in TDT-positive leukemia cells

Y Koc, A Urbano, E Sweeney, F Foss, R McCaffrey

Blood 82 (10), A115-A115 1993

 

Biomoduşatory effects of butyric acid derivatives on leukemia and lymphoma cells

FM Foss, Y Koc, D Sanders, M Obrien, D Faller, R McCaffrey

Blood 82 (10), A564-A564 1993

 

Continuous infusion versus bolus mitoxantrone in acute lymphoblastic leukemia

Y Koc, E Kansu, A Kars, Y Ozisil, G Tekuzman, E Baltalı, D Firat

Journal of Chemotherapy 5, 672-673 1993

 

Endothelin-1, 2 Levels in Behcet's disease

E Kansu, Y Koc, Z Koray, S Duru

Revue de Nedecine Interne 14, C 07-C 07 1993

 

2005-2008 yılları arasında kemik iliği transplantasyonu yapılan hastalarda febril nötropeni ataklarındaki kan kültürlerinden izole edilen mikroorganizmalar

Y Gürol, Y Öztürk, ZT Tekkanat, Y Koç, S Kocagöz, G Yılmaz 1993

 

C 07 Endothelin-1.2 levels in Behçet's disease

E Kansu, Y Koc, Z Koray, S Duru, F Batman, T Kansu, S Akkaya, B Elem, ...

La Revue de Médecine Interne 14, 26s 1993

 

Endothelin-1, 2 levels in Behcet's disease

Y Koç, E Kansu, Z Koray, S Duru

Excerpta Medica International Congress series1037 (1), 97-97 1993

 

Towards specific therapy in TdT-positive leukemia: Role of cordycepin

Y Koc, RP McCaffrey

Turkish Journal of Cancer 23 (4), 167-171 1993

 

Familial Behçet's disease.

T Akpolat, Y Koç, I Yeniay, G Akpek, I Güllü, E Kansu, S Kiraz, F Ersoy, ...

The European journal of medicine 1 (7), 391-395 1992

 

Vascular involvement in Behcet’s disease

Y Koc, Gullu i, Akpek G et al.

J Rheumatol 19 (3), 402-410 1992

 

Topical sucralfate therapy for oral ulcers in Behçet's disease: a randomized double-blind study

Y Koç, G Akpek, T Akpolat, I Güllü, E Kansu, S Kiraz, F Batman, S Duru, ...

Journal of dermatological treatment 3 (4), 197-199 1992

 

Aplastic anemia in a patient receiving tamoxifen

Y Koc, SA Kars, E Kansu, G Tekuzman, E Baltali, D Firat

International journal of hematology 54 (3), 263-264 1991

 

The value of ceruloplasmin levels in monitoring of patients with breast cancer

Ö Özyilkan, E Ünlü, E Baltali, G Tekuzman, N Güler, Y Koç, D FIRAT

Journal of Islamic Academy of Sciences 4 (2), 179-180 1991

 

Acute Lymphoblastic Leukemia in Breast Cancer: A Case Report

Y Koç, SA Kars, E Kansu, D Fırat

Turkish Journal of Cancer 21 (4), 151-153 1991

 

Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report

E Kansu, Y Koc, A Kars, M Alakavuklar, G Tekuzman, D Firat

 

Journal of chemotherapy (Florence, Italy) 1 (4 Suppl), 1268-1270 1989

Epidermal appendage tumors in xeroderma pigmentosum

SA Kars, Y Koç, Ş Ruacan, E Baltali, G Tekuzman, D Firat

Archives of Dermatology 123 (6), 713-714 1987

 

Galactomannan antigen test and real time pcr in diagnosis of invasive fungal infections in neutropenic bone marrow transplant patients

Y Gürol, Y Koc, I Karaltı Z Kirpitçi, Z Tekkanat Tazegün, ...

Yeditepe Medical Journal 5 (17), 343-348

 

Autologous/Allogeneic Stem Cell Transplantation following High-dose Sequential Chemotherapy in Patients with Stage III-IV Burkitt and Lymphoblastic Lymphoma: Long term survival …

B Gungor, C Unsal, İ Barista, M Adam, Y Koc

 

Bone Marrow Versus Mobilized Peripheral Blood Stem Cells in Haploidentical Transplants Using Posttransplantation Cyclophosphamide

MD Didier Blaise, MD Benedetto Bruno, MD Giuseppe Irrera, ...

Abstract's Content View

S Piemontese, F Ciceri, M Labopin, NC Gorin, H Huang, P Di Bartolomeo, …

 

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

E Polge, F Ciceri, A Bacigalupo, W Arcese, Y Koc, D Beelen

 

Kemoterapi ve Radyoterapi Toksisitesi, Etkileflimleri ve İlaç Monitorizasyonu

Koç Yener

 

Brentuximab Vedotin for Recurrent Hodgkin Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation: A Report From the EBMT Lymphoma Working Party

S Peggs, B Afanasyev, JL Diez-Martin, P Corradini, G Socie, S Robinson, …

 

Stem Hücre Transplantasyonunda Antiviral Tedavi ve Profilaksi

Y Koç

 

Microorganisms isolated from the blood cultures from stem cell transplantation patients during febrile neutropenia between 2005-2008

Y Gürol, Y Öztürk, ZT Tekkanat, Y Koç, S Kocagöz, G Yılmaz

Comparison of Transplant Outcomes in Patients with Acute Lymphoblastic Leukemia after Haploidentical Transplant with Post-Transplant Cyclophosphamide or Matched Unrelated Donor ...

MM Al Malki, D Yang, M Labopin, B Afanasyev, E Angelucci, A Bashey, ... Biology of Blood and Marrow Transplantation 26 (3), S58-S59

Outcomes of Acute Myelogenous Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation with Post-Transplant

Cyclophosphamide: Impact of Total Body ...

B Dholaria, M Labopin, E Angelucci, F Ciceri, JL Diez-Martin, B Bruno, ... Biology of Blood and Marrow Transplantation 26 (3), S110

Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the ...

E Maffini, M Labopin, D Blaise, F Ciceri, Z Gulbas, E Deconinck, ... Biology of Blood and Marrow Transplantation 26 (3), S287-S288

Comparison of Matched Sibling, Unrelated and Haploidentical Donor Transplants Using Post-Transplant Cyclophosphamide in Patients with Acute Myeloid Leukemia, a Study of the ...

J Sanz, JE Galimard, M Labopin, B Afanasyev, E Angelucci, F Ciceri, ... Biology of Blood and Marrow Transplantation 26 (3), S57-S58

Haploidentical transplant with post-transplant cyclophosphamide for T- cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party

A Bazarbachi, M Labopin, E Angelucci, Z Gülbas, H Ozdogu, M Arat, ... Biology of Blood and Marrow Transplantation

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

PH Prata, DJ Eikema, B Afansyev, P Bosman, F Smiers, JL Diez-Martin, ... Bone Marrow Transplantation, 1-9

Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study ...

A Ruggeri, M Labopin, B Savani, A Paviglianiti, D Blaise, F Volt, F Ciceri, ... Bone marrow transplantation 54 (12), 1987-1994

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

S Piemontese, A Boumendil, M Labopin, C Schmid, F Ciceri, W Arcese, ...

Journal of hematology & oncology 12 (1), 68

Bone Marrow Versus Mobilized Peripheral Blood Stem Cells for Non T Depleted Haploidentical Transplantations with Post Transplantation Cyclophosphamide in Acute Lymphoblastic ...

A Nagler, M Labopin, E Angelucci, Y Koc, M Arat, P Pioltelli, S Sica, ...

Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid

Leukemia, a Comparative Study of the ALWP EBMT

J Sanz, JE Galimard, BV Afanasyev, E Angelucci, F Ciceri, D Blaise, ...

Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...

CD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using ...

E Maffini, M Labopin, D Blaise, F Ciceri, Z Gulbas, E Daguindau, ...

Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...

Outcomes of Total Body Irradiation-Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic

Cell Transplantation with Post-Transplant ...

B Dholaria, M Labopin, E Angelucci, F Ciceri, JL Díez-Martín, B Bruno, ...

Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical ...

G Battipaglia, M Labopin, RM Hamladji, D Blaise, P Chevallier, A Gerbitz, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...

Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic ...

M Carré, R Porcher, J Finke, G Ehninger, L Koster, D Beelen, A Ganser, ... Biology of Blood and Marrow Transplantation

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies ...

A Radujkovic, S Dietrich, HJ Blok, A Nagler, F Ayuk, J Finke, J Tischer, ... Biology of Blood and Marrow Transplantation 25 (10), 2008-2016

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma–a LWP‐EBMT study A Bazarbachi, A Boumendil, H Finel, L Castagna, A Dominietto, D Blaise, ... British journal of haematology

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

W Wiktor-Jedrzejczak, J Drozd-Sokolowska, DJ Eikema, J Hoek, M Potter, ... Bone marrow transplantation 54 (9), 1391-1398

Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study ...

G Battipaglia, A Boumendil, M Labopin, F Ciceri, J Tischer, M Stelljes, ... Bone marrow transplantation 54 (9), 1499-1510

Post-transplant cyclophosphamide-based GVHD prophylaxis compared to standard prophylaxis in patients with lymphoma receiving HLA identical transplantation: A retrospective ...

S Bramanti, A Boumendil, H Finel, I Khvedelidze, B Afanasyev, N Schmitz, ... BONE MARROW TRANSPLANTATION 54, 107-108

Myeloablative conditioning may contribute to disease control after stem cell transplantation in blastic plasmacytoid dentric cell neoplasia

S Dietrich, H Finel, JJ Lu, A Boumendil, H Sengeloev, G Socie, ... BONE MARROW TRANSPLANTATION 54, 108-109

Haploidentical transplant with post-transplant cyclophosphamide for T- cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT ...

A Bazarbachi, M Labopin, E Angelucci, Z Gulbas, H Ozdogu, M Arat, ... BONE MARROW TRANSPLANTATION 54, 19-20

Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry ...

A Bondanza, L Ruggeri, M Noviello, DJ Eikema, C Bonini, C Chabannon, ... Bone marrow transplantation 54 (6), 867-876

Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over

N Santoro, M Labopin, F Ciceri, MT Van Lint, D Nasso, D Blaise, ... Cancer 125 (9), 1499-1506

Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML-No Association with Graft-Versus-Host ...

A Shimoni, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, Z Gulbas, ... Biology of Blood and Marrow Transplantation 25 (3), S242-S243

HLA-Matched Sibling Versus Haploidentical Hematopoietic Cell Transplantation (HCT) in Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)

A Rashidi, M Hamadani, HL Wang, J Bolanos, JW Lee, SO Ciurea, ... Biology of Blood and Marrow Transplantation 25 (3), S59-S60

Family mismatched allogeneic stem cell transplantation for myelofibrosis: report from the chronic malignancies Working Party of European Society for Blood and Marrow ...

K Raj, DJ Eikema, DP McLornan, E Olavarria, HJ Blok, S Bregante, ... Biology of Blood and Marrow Transplantation 25 (3), 522-528

Outcomes of haploidentical transplantation in patients with relapsed multiple myeloma: an EBMT/CIBMTR report

F Sahebi, L Garderet, AS Kanate, DJ Eikema, NS Knelange, OFD Alvelo, ... Biology of Blood and Marrow Transplantation 25 (2), 335-342

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide

A Shimoni, M Labopin, F Lorentino, MT Van Lint, Y Koc, Z Gülbas, ... Leukemia 33 (1), 230-239

HLA-mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis

M Robin, R Porcher, A Ruggeri, D Blaise, C Wolschke, L Koster, ... Biology of Blood and Marrow Transplantation 25 (1), 114-120

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on ...

A Ruggeri, M Labopin, A Bacigalupo, B Afanasyev, JJ Cornelissen, ... Journal of hematology & oncology 11 (1), 40

19 2019

Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell 2018 Transplantation with Post-Transplant Cyclophosphamide in Patients with AML-No Association with Graft-Versus-Host ...

A Shimoni, M Labopin, E Angelucci, D Blaise, F Ciceri, Y Koc, Z Gülbas, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 ...

Influence of Donor Type, Stem Cell Source and Conditioning Regimen 2018 on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A ...

A Bazarbachi, A Boumendil, H Finel, L Castagna, A Dominietto, D Blaise, ... Blood 132 (Supplement 1), 484-484

Haploidentical transplantation using high dose post-transplant cyclophosphamide for patients with aplastic anemia: the European Group for Blood and Marrow Transplantation ...

PH Prata, B Afanasyev, DJ Eikema, F Smiers, C Knol, JL Diez-Martin, ...

Blood, The Journal of the American Society of Hematology 132 (Supplement 1 ...

Prediction of Leukemia-Free Survival Following Haploidentical Stem Cell Transplantation in Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

R Shouval, JA Fein, M Labopin, F Ciceri, E Angelucci, D Blaise, J Tischer, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 ...

Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party study

A Paviglianiti, KT Maio, V Rocha, E Gehlkopf, N Milpied, A Esquirol, ... Biology of Blood and Marrow Transplantation 24 (11), 2265-2270

Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation ...

Z Li, M Labopin, F Ciceri, D Blaise, J Tischer, G Ehninger, MT Van Lint, ... American journal of hematology 93 (6), 769-777

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working ...

SP Robinson, A Boumendil, H Finel, KS Peggs, P Chevallier, J Sierra, ... Bone marrow transplantation 53 (5), 617-624

Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide

A Ruggeri, M Labopin, A Bacigalupo, Z Gülbas, Y Koc, D Blaise, B Bruno, ... Cancer 124 (7), 1428-1437

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the ...

S Cesaro, R Crocchiolo, G Tridello, N Knelange, MT Van Lint, Y Koc, ... Bone marrow transplantation 53 (4), 422

Haploidentical Transplantation Outcomes for Secondary Acute Myeloid Leukemia—on Behalf of the ALWP of the EBMT

Z Li, M Labopin, BN Savani, F Ciceri, D Blaise, J Tischer, G Ehninger, ... Biology of Blood and Marrow Transplantation 24 (3), S292-S293

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

G van Gorkom, M van Gelder, DJ Eikema, HJ Blok, MT van Lint, Y Koc, ... Bone marrow transplantation 53 (3), 255-263

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation

J Canaani, BN Savani, M Labopin, XJ Huang, F Ciceri, W Arcese, Y Koc, ... American journal of hematology 93 (2), 246-253

The differential diagnostic role of PET-CT in sarcoidosis and lymphoma

AB Kargi, H Süslü, Ç Ünsal, OF Boztepe, Y Koç Current Thoracic Surgery 3 (1)

Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study

A Paviglianiti, K Tozatto-Maio, V Rocha, E Gehlkopf, N Milpied, A Esquirol, ... Blood 130 (Supplement 1), 3318-3318

KIR-Ligand Mismatching Is Associated with Inferior Survival in Patients with Acute Leukemia Following T-Cell Replete Peripheral-Blood Stem Cell Haplo-Identical Transplantation ...

A Shimoni, M Labopin, F Lorentino, MT Van Lint, K Yener, Z Gülbas, ... Blood 130 (Supplement 1), 3302-3302

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor ...

A Ruggeri, M Labopin, BV Afanasyev, JJ Cornelissen, A Elmaagacli, ... Blood 130 (Supplement 1), 215-215

Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of ...

M Carre, R Porcher, J Finke, G Ehninger, DW Beelen, L Koster, A Ganser, ...

(Supplement 1), 2028-2028

Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant:

A Registry Study from the Chronic ...

E Forcade, S Chevret, J Finke, G Ehninger, FA Ayuk, DW Beelen, L Koster, ... Blood 130 (Supplement 1), 520-520

Haplo-Identical Stem Cell Transplantation for Patients with Multiple Myeloma Who Relapsed after Autografting. a Study from the Cmwp of EBMT

N Kroeger, DJ Eikema, NS Knelange, Y Koc, JM Moraleda, P Dreger, ... Blood 130 (Supplement 1), 2046-2046

Donor Age Determines Outcome in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation

J Canaani, BN Savani, M Labopin, XJ Huang, F Ciceri, W Arcese, Y Koc, ... Blood 130 (Supplement 1), 850-850

An EBMT Analysis of Matched Sibling, Mismatched Family or Matched Unrelated Donors for Allogeneic Stem Cell Transplants in MDS

K Raj, DJ Eikema, G Ehninger, C Wolschke, L Koster, G Socié, J Finke, ... Blood 130 (Supplement 1), 4593-4593

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

N Santoro, A Ruggeri, M Labopin, A Bacigalupo, F Ciceri, Z Gülbaş, ... Journal of hematology & oncology 10 (1), 113

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

N Santoro, A Ruggeri, M Labopin, A Bacigalupo, F Ciceri, Z Gülbaş, ... Journal of hematology & oncology 10 (1), 113

Haploidentical transplant in patients with myelodysplastic syndrome M Robin, R Porcher, F Ciceri, MT van Lint, S Santarone, G Ehninger, ... Blood advances 1 (22), 1876-1883

Post transplant cyclophosphamide (PT-Cy) in association to standard GVHD prophylaxis in sibling and unrelated allogeneic stem cell transplantation (HSCT) for patients with ...

A Ruggeri, M Labopin, B Afanasyev, J Cornelissen, B Glass, D Blaise, ... Bone Marrow Transplantation 52

Anti GvHD prophylaxis shape the effect of HLA mismatches on the unshared haplotype in T-cell repleted haploidentical stem cell transplantation: a study from the Acute Leukemia ...

F Lorentino, M Labopin, K Fleishhauer, F Ciceri, C Mueller, A Ruggeri, ... Bone Marrow Transplantation 52

Comparable outcomes using a CMV-matched or a mismatched donor for CMV plus patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: A study from IDWP and ALWP of ...

S Cesaro, R Crocchiolo, G Tridello, N Knelange, MT Van Lint, Y Koc, ...

NATURE PUBLISHING GROUP

Long-term follow-up of patients undergoing reduced intensity allogeneic stem cell transplantation for mantle cell lymphoma. a study of the Lymphoma Working Party-EBMT: O140

S Robinson, A Boumendil, H Finel, K Thomson, P Chevallier, J Sierra, ... Bone Marrow Transplantation 52

A risk-factor analysis for overall survival in patients with acute leukemia that relapse following T-replete haploidentical transplantation: On behalf of the acute leukemia ...

S Piemontese, M Labopin, F Ciceri, C Schmid, A Ruggeri, W Arcese, ... Bone Marrow Transplantation 52

Haplo-identical transplantation (haplo-HSCT) in patients with myelodysplastic syndrome (MDS): a report from the European Society of Blood and Marrow Transplantation

M Robin, R Porcher, L Koster, F Ciceri, MT van Lint, P Di Bartolomeo, ... NATURE PUBLISHING GROUP

Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the Acute Leukemia ...

J Canaani, BN Savani, M Labopin, X Huang, F Ciceri, W Arcese, J Tischer, ... haematologica 102 (6), 1066-1074

GVHD PROPHYLAXIS MODULATES THE INFLUENCE OF HLA MISMATCHES ON THE UNSHARED HAPLOTYPE ON THE OUTCOMES AFTER T-CELL REPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION

F Lorentino, M Labopin, K Fleischhauer, F Ciceri, CR Mueller, A Ruggeri, ... HLA 89 (6), 361-361

The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis

F Lorentino, M Labopin, K Fleischhauer, F Ciceri, CR Mueller, A Ruggeri, ... Blood advances 1 (11), 669-680

ABO Mismatching and Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia—a Report from the ALWP of the EBMT

BN Savani, M Labopin, J Canaani, XJ Huang, W Arcese, J Tischer, Y Koc, ... Biology of Blood and Marrow Transplantation 23 (3), S36-S37

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant

A Ruggeri, Y Sun, M Labopin, A Bacigalupo, F Lorentino, W Arcese, ... Haematologica 102 (2), 401-410

Impact of Conditioning Regimen on Outcomes of T-Replete Haplo- Identical Transplantation for Patients Over 45 Years-Old with AML: A

Study On Behalf Of the Acute Leukemia Working ...

D Nasso, M Labopin, A Ruggeri, F Ciceri, MT Van Lint, W Arcese, ... Haematologica, 132-132

Mother donors improve outcomes after HLA haploidentical hematopoietic transplantation: a retrospective study by the Cell Therapy and Immunobiology Working Party of the EBMT

A Velardi, L Ruggeri, D Ziagkos, A van Biezen, M Merluzzi, A Bondanza, ... Blood, The Journal of the American Society of Hematology 128 (22), 3472-3472

Use of bone marrow or peripheral blood stem cell grafts in non T cell depleted haploidentical transplants using post-transplant cyclophosphamide, an ALWP-EBMT analysis

A Ruggeri, M Labopin, A Bacigalupo, Z Gülbas, Y Koc, D Blaise, B Bruno, ... Blood, The Journal of the American Society of Hematology 128 (22), 1165-1165

Outcomes of mismatched related allogeneic stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the

chronic malignancies working party ...

G van Gorkom, M van Gelder, D Ziagkos, HJ Blok, MT van Lint, Y Koc, ... Blood, The Journal of the American Society of Hematology 128 (22), 3504-3504

Allogeneic genetically modified T Cells (HSV-TK) as adjunctive treatment in haploidentical hematopoietic stem-cell transplantation

(haplo-HSCT) of adult patients with high-risk ...

M Mohty, M Labopin, A Velardi, MT van Lint, D Bunjes, B Bruno, ...

Blood, The Journal of the American Society of Hematology 128 (22), 672-672

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

MT Rubio, BN Savani, M Labopin, S Piemontese, E Polge, F Ciceri, ... Journal of hematology & oncology 9 (1), 25

ABO mismatch and haploidentical hematopoietic stem cell transplantation in AML-a report from the ALWP of the EBMT

BN Savani, L Myriam, C Jonathan, X jun Huang, C Fabio, A William, ... BMT TANDEM, 1-2

Impact of graft versus host disease prophylaxis on outcomes of unmanipulated haploidentical stem cell transplantation: post-transplant

cyclophosphamide versus antithymocyte ...

A Ruggeri, Y Sun, M Labopin, F Lorentino, A Bacigalupo, W Arcese, ... Bone Marrow Transplantation 51

Mother donors improve outcomes after HLA haploidentical T cell- depleted hematopoietic transplantation: A Retrospective Study by the Cell Therapy and Immunobiology Working Party ...

A Velardi, D Ziagkos, A van Biezen, L Ruggeri, M Merluzzi, A Bondanza, ... Bone Marrow Transplantation 51

HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia ...

F Lorentino, F Ciceri, M Labopin, A Ruggeri, Z Guelbas, Y Koc, W Arcese, ... Bone Marrow Transplantation, S28-S29

Refined graft-versus-host disease-free/relapse-free survival-a novel outcome endpoint for haploidentical transplantation in adults with acute leukemia: on behalf of ALWP-EBMT

S Sestili, A Ruggeri, M Labopin, MT Van Lint, A Velardi, W Arcese, G Zafer, ... Bone Marrow Transplantation 51

Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report

of 1578 patients from Acute ...

E Brissot, M Labopin, F Ciceri, M Bornhäuser, J Tischer, M Stelljes, Y Koc, ... Bone Marrow Transplantation, S65-S65

Comparison of outcome after haplo-identical, HLA-mismatched unrelated donor and unrelated cord blood transplantation in patients

with myelodysplastic syndrome (MDS) and ...

M Robin, R Porcher, MT Van Lint, F Ciceri, J Tisher, J Sanz, U Platzbecker, ... Bone Marrow Transplantation, S73-S73

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the ...

A Bondanza, L Ruggeri, D Ziagkos, C Bonini, C Chabannon, N Bootsman, ... Blood, The Journal of the American Society of Hematology 126 (23), 1929-1929

Results of Allogeneic Transplantation As First Line Rescue Therapy in Patients with Multiple Myeloma Relapsing to a Prior Autograft: Role of

Conditioning Regimen

JA Perez-Simon, FJ Marquez-Malaver, C Knol, S Iacobelli, D Blaise, ...

Blood, The Journal of the American Society of Hematology 126 (23), 4373-4373

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the ...

A Bondanza, L Ruggeri, D Ziagkos, C Bonini, C Chabannon, N Bootsman, ... Blood, The Journal of the American Society of Hematology 126 (23), 1929-1929

HLA disparities impact on outcomes after unmanipulated haploidentical hematopoietic stem cells transplantation (HaploSCT) in acute leukemia: a study from the Acute Leukemia ...

F Lorentino, F Ciceri, M Labopin, Z Gülbas, Y Koc, W Arcese, B Bruno, ... Blood, The Journal of the American Society of Hematology 126 (23), 399-399

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the ...

A Bondanza, L Ruggeri, D Ziagkos, C Bonini, C Chabannon, N Bootsman, ... Blood, The Journal of the American Society of Hematology 126 (23), 1929-1929

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

A Ruggeri, M Labopin, G Sanz, S Piemontese, W Arcese, A Bacigalupo, ... Leukemia 29 (9), 1891-1900

Unmanipulated haploidentical bone marrow transplantation and post- transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update

A Bacigalupo, A Dominietto, A Ghiso, C Di Grazia, T Lamparelli, ... Bone marrow transplantation 50 (2), S37-S39

AUTOLOGOUS STEM CELL TRANSPLANTATION WITH HIGH-DOSE MITOXANTRONE AND MELPHALAN IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA: LONG-TERM SURVIVAL AND TOXICITY DATA

B Gungor, M Yeral, M Adam, C Unsal, C Boga, H Ozdogu, Y Koc HAEMATOLOGICA 100, 280-280

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

S Piemontese, F Ciceri, M Labopin, A Bacigalupo, H Huang, S Santarone, ... Leukemia 29 (5), 1069-1075

Unmanipulated haploidentical stem cell transplantation after reduced intensity or ablative conditioning regimen for the treatment of acute leukemia-a report from the acute ...

MT Rubio, BN Savani, M Labopin, E Polge, F Ciceri, A Bacigalupo, ... BONE MARROW TRANSPLANTATION 50, S24-S25

Allogeneic Stem-Cell Transplantation In AML with Myeloablative compared to Reduced Intensity Conditioning: 10 Years Later. A report on behalf of the ALWP of EBMT

A Shimoni, M Labopin, F Ciceri, A Bacigalupo, W Arcese, Y Koc, D Beelen, ... BONE MARROW TRANSPLANTATION 50, S11-S11

Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study

A Ruggeri, M Labopin, GF Sanz, S Piemontese, W Arcese, A Bacigalupo, ... Blood, The Journal of the American Society of Hematology 124 (21), 1227-1227

UNMANIPULATED GRAFT HAPLOINDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION (HAPLO-SCT) IN ACUTE LEUKEMIA: A LONG-TERM FOLLOW-UP SURVEY ON BEHALF OF THE ACUTE LEUKEMIA WORKING ...

S Piemontese, F Ciceri, M Labopin, N Gorin, H Huang, P Di Bartolomeo, ... Bone Marrow Transplantation 49

COMPARATIVE STUDY OF UNRELATED CORD BLOOD AND NON T- CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA

A Ruggeri, L Myriam, S Piemontese, W Arcese, A Bacigalupo, D Blaise, ... Bone Marrow Transplantation 49, S57-S58

EBMT PROSPECTIVE NON-INTERVENTIONAL STUDY ON ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN T-PROLYMPHOCYTIC LEUKEMIA (T-PLL). PRELIMINARY ANALYSIS

OF 43 PATIENTS: PH-O066

W Wiktor-Jedrzejczak, S Iacobelli, J Hoek, M Drozd-Sokolowska, M Potter, ... Bone Marrow Transplantation 49

COMPARATIVE STUDY OF UNRELATED CORD BLOOD AND NON T- CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA

A Ruggeri, L Myriam, S Piemontese, W Arcese, A Bacigalupo, D Blaise, ... Bone Marrow Transplantation 49, S57-S58

Unmanipulated Graft Haploindentical Allogeneic Stem Cell Transplantation (Haplo-SCT) In Acute Leukemia: A Long-Term Follow- Up Survey On Behalf Of The Acute Leukemia Working ...

S Piemontese, F Ciceri, M Labopin, NC Gorin, H Huang, P Di Bartolomeo, ... Blood, The Journal of the American Society of Hematology 122 (21), 2105-2105

EBMT Prospective Non-Interventional Study On Allogeneic Hematopoietic Stem Cell Transplantation In T-Prolymphocytic Leukemia (T-PLL). Preliminary Analysis Of 43 Patients

WW Jedrzejczak, S Iacobelli, JDC Hoek, JE Drozd-Sokolowska, M Potter, ... Blood, The Journal of the American Society of Hematology 122 (21), 3336-3336

Mesenchymal stem cells in the management of therapy-resistant graft- versus-host disease: Turkish experience

G Sezgin, M Pehlivan, G Sucak, Y Koc, P Topcuoglu, A Unal, A Tanyeli, ... Bone Marrow Transplantation 48, S83-S83

Mantle Cell Lymphoma: Decision Making for Transplant

Y Koc, T Demirer

New Advances in Stem Cell Transplantation, 319

High complete remission rate and durable remissions achieved with rational use of autologous stem‐cell transplantation, thalidomide maintenance, and non‐myeloablative ...

B Oyan, Y Koc, E Ozdemir, A Kars, A Turker, G Tekuzman, E Kansu Clinical transplantation 23 (6), 839-847

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

S Cesaro, HH Hirsch, M Faraci, J Owoc-Lempach, A Beltrame, A Tendas, ... Clinical infectious diseases 49 (2), 233-240

Validation of FDG-PET/CT in evaluation of early remission in patients with refractory lymphoma after treatment with high dose chemotherapy (HDT) and autologous stem cell ...

N Selcuk, G Civi, H Selcuk, T Toklu, Y Koc

Journal of Nuclear Medicine 49 (supplement 1), 338P-338P

A retrospective EBMT survey on the use of cidofovir for BK-related haemorrhagic cystitis after allogeneic haematopoietic stem cell transplant

S Cesaro, Y Koc, A Tendas, M Caniglia, A Beltrame, N Khanna, M Faraci, ... EBMT 2008 41 (Suppl. 1), 60-60

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory ...

Y Urun, H Abali, B Oksuzoglu, B Budakoglu, N Yildirim, T Guler, G Ozet, ... Blood, The Journal of the American Society of Hematology 110 (11), 4438-4438

Bortezomib, Dexamethasone and Concomitant or Sequential Thalidomide (VTD): An Effective Combination for Relapsed/Refractory Multiple Myeloma Failing Thalidomide and Dexamethasone.

E Ozdemir, Y Koc, A Kars, A Turker, G Tekuzman, E Kansu

Blood, The Journal of the American Society of Hematology 110 (11), 4810-4810

Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma at Yeditepe University Hospital

S Yüce, G Kalayci, S Aktas, D Aydin, B Oyan, Y Koc Artificial Organs 31 (11)

Hemorrhagic cystitis due to viral infection following hematopoietic stem cell transplantation

C Obek, T Kocagoz, S Aktas, F Yencilek, BO Uluc, Y Koc JOURNAL OF ENDOUROLOGY 21, A61-A61

Splenectomy status of the patient may have impact on response to donor lymphocyte infusions

D Uckan-Cetinkaya, S Unal, M Cetin, Ü Sarikabadayi, D Aktaş, Y Koc Leukemia 21 (9), 2049-2050

Is there a predictive role for GA-67 scintigraphy in patients with lymphoma undergoing autologous stem cell transplantation?

P Kiratli, P Kiratli, B Erbas, E Ozdemir, Y Koc HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 480-480

The autologous hematopoietic stem cell transplantation in adult patients with lymphoma: Turkish Bone Marrow Transplantation Registry results.

F Arpaci, S Ataergın, G Gürman, S Çağirgan, M Arat, A Özet, M Ayli, ... Turkish Journal of Cancer 37 (2)

Ga-67 scintigraphy in lymphoma patients undergoing bone marrow transplantation.

PÖ Kiratli, B Erbaş, E Özdemır, Y Koç Turkish Journal of Cancer 37 (2)

Possible BK virus outbreak in haematopoietic stem cell transplant recipients: P638

M Sonmezoglu, S Yirmibescik, C Obek, D Colak, T Kocagoz, Y Koc Clinical Microbiology & Infection 13

256: Hematopoietic stem cell transplantation for hematological diseases at Yeditepe University Hospital

S Yirmibescik, V Senkal, G Kalayci, S Aktas, D Aydin, M Sonmezoglu, ... Biology of Blood and Marrow Transplantation 13 (2), 94

Bacillus Circulans Paracardiac Infection in Non-Hodgkin Lymphoma–

Y Gurol, Z Kipritci, NA Selcuk, Y Koc, S Kocagoz Prague medical report 108 (1), 19-22

P638 Possible BK virus outbreak in haematopoietic stem cell transplant recipients

M Sonmezoglu, S Yirmibescik, C Obek, D Colak, T Kocagoz, Y Koc International Journal of Antimicrobial Agents, S150

Nephrologic complications in stem cell transplantation

U Yakupoglu, BO Uluc, Y Koc

NEPHROLOGY DIALYSIS TRANSPLANTATION 22, 56-57

Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis

E Ozdemir, Y Koc, E Kansu

American journal of hematology 81 (6), 474-474

Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal

photopheresis

B Oyan, Y Koc, S Emri, E Kansu Medical Oncology 23 (1), 125-129

Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?

B Oyan, Y Koc

Annals of oncology 17 (2), 349-350

Phase III trial of valacyclovir for the prevention of shingles after hematopoietic stem cell transplantation

AK Klein, J DesJardins, Y Koc, KB Miller, DS Schenkein, KS Sprague, ... Biology of Blood and Marrow Transplantation 12 (2), 138-139

High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma

B Oyan, Y Koc, E Ozdemir, A Kars, A Turker, G Tekuzman, E Kansu Leukemia & lymphoma 47 (8), 1545-1552

Predictive Value of Ga-67 Scintigraphy in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation

PO Kiratli, Y Koc, B Erbas, E Ozdemir

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 32, S126-S126

Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell ...

B Oyan, Y Koc, E Ozdemir, A Kars, A Turker, G Tekuzman, E Kansu Biology of Blood and Marrow Transplantation 11 (9), 688-697

IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation

H Abali, B Oyan, Y Koc, A Kars, I Barista, A Uner, A Turker, F Demirkazik, ... American journal of clinical oncology 28 (3), 264-269

High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL

B Oyan, Y Koc, E Ozdemir, E Kansu Bone Marrow Transplantation 35

Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle ...

B Oyan, Y Koc, E Kansu

International journal of hematology 81 (2), 155-158

Nonmyeloablative Allogeneic Stem Cell Transplantation: Hacettepe University Institute of Oncology Experience.

Y Koc, E Ozdemir, B Oyan, E Kansu

Blood, The Journal of the American Society of Hematology 104 (11), 5155-5155

High-Dose Sequential Chemotherapy (HDSC) in Support of Autologous 2004 Stem Cell Transplantation (ASCT) in Patients with Relapsed/Refractory

Hodgkin Lymphoma (HL) and Non-Hodgkin ...

B Oyan, Y Koc, E Ozdemir, E Kansu

Blood, The Journal of the American Society of Hematology 104 (11), 5231-5231

Successful allogeneic marrow transplantation from donors with 2004

hematologic malignancies.

Y Koç, B Oyan, MS Akhtar, DP Schenkein, KB Miller Turkish Journal of Cancer 34 (3)

A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia

Y Koc, B Oyan, A Kars, G Tekuzman, H Canpinar, E Kansu Hematological oncology 22 (2), 43-53

PRİMER KUTANÖZ LENFOMA: RETROSPEKTİF DEĞERLENDİRME 2004 A Ferahbaş, B Eser, Ö Canöz, Y Ulaş, İ Sarı, O Kontaş, S Utaş, M Çetin, ...

Turkish Journal of Haematology (Supplement) 21 (3), 1

Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)

B Oyan, G Tekuzman, I Barista, Y Ozisik, kars, Ayse, A Turker, S Yalcin, ... ANNALS OF ONCOLOGY 15, 153-153

Achieving high remission rate with use of autologous HSCT, thalidomide maintenance and non-myeloablative allogeneic HSCT in patients with multiple myeloma.

B Oyan, Y Koc, A Kars, A Turker, G Tekuzman, E Kansu BLOOD 102 (11), 390B-390B

Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma

GB ŞENTÜRK, S ŞAHİN, B OYAN, Y KOÇ, A KARS, A TÜRKER, ... Turkish Journal of Cancer 33 (1), 23-26

Akut myeloid lösemide transplantasyon

B OYAN, Y KOÇ

Turkiye Klinikleri Journal of Hematology 1 (1), 28-32

Chronic graft-versus-host disease after allogeneic stem cell transplantation

E Kansu, Y Koc, KM Sullivan

Turkish Journal of Cancer 33 (1), 9-22

Hematopoietic stem cell transplantation in hematologic malignancies

and solid tumours: Hacettepe University Institute of Oncology experience

B Oyan, Y Koc, A Kars, A Türker, C Akyüz, D Güç, A ÜNER, Ş RUACAN, ... Turk J Cancer 33, 27-39

IIVP salvage regimen induces high response rates in patients with relapsed FED or NHL prior to autologous HSCT.

H Abali, Y Koc, B Oyan, F Tekin, G Tekuzman, E Kansu Blood 100 (11), 294B-294B

Successful salvage with high-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with Rituximab in patients with primary refractory mantle cell ...

B Oyan, Y Koc, F Tekin, E Kansu BLOOD 100 (11), 471B-471B

High-dose sequential chemotherapy in refractory Hodgkin's and non-Hodgkin's lymphoma.

B Oyan, Y Koc, E Kansu BLOOD 100 (11), 471B-471B

Problems encountered during IFN-alfa therapy following autologous stem cell transplantation: a preliminary report

S Kav, Y Koc, E Kansu

BONE MARROW TRANSPLANTATION 29, S261-S262

Factors for chronic GvHD after allogeneic peripheral blood stem cell transplants (allo-PBSCT) in patients with acute leukemia (AL)

V Rocha, M Labopin, Y Koc, J Finke, A Gratwohl, A Fassas, A Schwaren, ... BONE MARROW TRANSPLANTATION 29, S73-S74

Risk factors for chronic GvHD after allogeneic peripheral blood stem cell transplants (allo-PBSCT) in patients with acute leukemia (AL).

V Rocha, M Labopin, Y Koc, J Finke, A Gratwohl, A Fassas, AP Schwarer, ... BLOOD 98 (11), 397A-398A

IIVP regimen for salvage therapy in patients with relapsed lymphoma prior to autologous stem cell transplantation.

H Abali, A Karaoglu, G Tekuzman, Y Koc, E Kansu BLOOD 98 (11), 389B-389B

Basic concepts in autologous peripheral blood stem cell transplantation: an educational course for nurses

S Kav, Y Koc, N Ecioglu, E Kansu

BONE MARROW TRANSPLANTATION 27, S393-S393

Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor

DP Schenkein, Y Koc, T Alcindor, EA Stadtmauer, KB Miller, BW Cooper, ... Biology of Blood and Marrow Transplantation 6 (4), 448-455

Response to Gratwohl et al

K Miller, D Schenkein, G Jabro, Y Koc, T Boyle, J Ravalese, D Wazer Biology of Blood and Marrow Transplantation 6 (2A), 213-213

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome

Y Koc, KB Miller, DP Schenkein, J Griffith, M Akhtar, J DesJardin, ... Biology of Blood and Marrow Transplantation 6 (1), 44-49

Second allogeneic bone marrow transplant after relapse of hematologic malignancies following first autologous or allogeneic bone marrow transplant.

T Roberts, Y Koc, K Sprague, H Grodman, D Mogavero, E Berkman, ... BLOOD 94 (10), 380B-380B

A randomized trial of 2 different priming methods for stem cell mobilization in patients with relapsed Hodgkin's disease and non- Hodgkin's lymphoma.

DP Schenkein, CE O'Connor, JA Morelli, E Berkman, JK Erban, ... Blood 94 (10), 326A-327A

Outcome of patient's with primary refractory non-Hodgkins lymphoma (NHL) and Hodgkin's disease (HD) treated with allogeneic or autologous bone marrow transplant (BMT).

T Roberts, Y Koc, K Sprague, H Grodman, E Berkman, D Schenkein, ... BLOOD 94 (10), 168A-169A

Mycophenolate mofetil (MMF) for the treatment of chronic graft versus host disease (CGVHD) of the liver.

T Roberts, Y Koc, K Sprague, H Grodman, E Berkman, D Schenkein, ... Blood 94 (10), 159A-159A

Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation

G Jabro, Y Koc, T Boyle, DP Schenkein, J Ravalese, D Wazer, KB Miller Biology of Blood and Marrow Transplantation 5 (3), 173-179

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation

Y Koc, KB Miller, DP Schenkein, P Daoust, K Sprague, E Berkman Cancer: Interdisciplinary International Journal of the American Cancer ...

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk

EA Engels, CA Ellis, SE Supran, CH Schmid, M Barza, DP Schenkein, ... Clinical infectious diseases 28 (2), 256-266

Therapy of diffuse aggressive lymphomas

Y Koc, DP Schenkein

Diagnostic and Therapeutic Advances in Hematologic Malignancies, 47-73

A-randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in previously untreated patients with acute myeloblastic leukemia.

Y Koc, E Kansu, A Kars, G Akpek, G Tekuzman, D Firat BLOOD 92 (10), 217B-217B

High-dose chemoradiotherapy and peripheral stem cell rescue for primary resistant or recurrent myeloma: Long-term follow-up of phase I- II study.

DP Schenkein, Y Koc, T Alcindor, EA Stadtmauer, KB Miller, HM Lazarus BLOOD 92 (10), 663A-663A

Treatment of relapsed/refractory or secondary acute leukemias with allogeneic bone marrow transplantation.

Y Koc, K Sprague, DP Schenkein, E Berkman, KB Miller BLOOD 92 (10), 351B-351B

Ganciclovir administration for cytomegalovirus infection prophylaxis

delays onset of varicella zoster virus reactivation in allogeneic bone

marrow transplant recipients.

Y Koc, K Miller, DP Schenkein, J DesJardin, DR Snydman Blood 92 (10), 280A-281A

Vancomycin-resistant enterococcal infections in bone marrow transplant recipients

Y Koc, DR Snydman, DS Schenkein, KB Miller Bone marrow transplantation 22 (2), 207

Arginine butyrate downregulates p 210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells

A Urbano, Y Koc, FM Foss Leukemia 12 (6), 930-936

Current management of diffuse aggressive lymphomas: Role of dose-intensive chemotherapy and peripheral stem cell/marrow transplantation-II

Y KOÇ

Turkish Journal of Cancer 28 (4), 151-165

Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies

Y Koc, G Akpek, E Kansu, A Kars, G Tekuzman, E Baltali, N Guler, ... Cancer investigation 16 (6), 355-365

Comparison of standard and short course methotrexate (MTX) in combination with adjusted dose continuous infusion cyclosporin-A (CSA) to prevent acute graft versus host disease ...

Y Koc, KB Miller, DP Schenkein, K Sprague, E Berkman BLOOD 90 (10), 4413-4413

The role of splenic irradiation (XRT) prior to bone marrow 1997

transplantation (BMT) for chronic myeloid leukemia (CML).

G Jabro, Y Koc, K Miller, T Boyle, J Ravalese, D Schenkein, K Sprague, ... BLOOD 90 (10), 1669-1669

Varicella zoster virus infections (VZV) following allogeneic bone marrow transplantation (BMT): Frequency, risk factors, clinical outcome and antiviral prophylaxis.

Y Koc, K Miller, D Schenkein, K Sprague, E Berkman, J Desjardin, ... Blood 90 (10), 2420-2420

Management of acute myeloid leukemia and bone marrow transplantation in the elderly

Y KOÇ, KB MILLER

Turkish Journal of Cancer 27 (4), 143-160

Augmentation of vincristine cytotoxicity by megestrol acetate

S Tansan, Y Koç, H Aydin, G Urbano, R McCaffrey Cancer chemotherapy and pharmacology 39 (4), 333-340

Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells.

Y Koc, AG Urbano, EB Sweeney, R McCaffrey Leukemia 10 (6), 1019-1024

Urinary neopterin levels as an indicator of disease activation in Behçet’s disease

Z Altindağ, G Şahin, G Akpek, Y Koç, A Işimer, E Kansu, S Duru Pteridines 6 (2), 79-83

2', 3'-Dideoxyadenosine killing of TdT-positive cells is due to a trace contaminant.

Y Koc, R McCaffrey Leukemia 9 (1), 53-57

CORDYCEPIN-INDUCED APOPTOTIC CELL-DEATH IN TDT- POSITIVE LEUKEMIA/LYMPHOMA CELLS IS ASSOCIATED WITH NITRIC-OXIDE FORMATION

Y KOC, T COTTER, R MCCAFFREY BLOOD 84 (10), A285-A285

ARGININE BUTYRATE INDUCES APOPTOSIS IN SELECTED HEMATOPOIETIC TUMOR-CELL LINES

Y KOC, R MCCAFFREY, F FOSS BLOOD 84 (10), A141-A141

Combined antiproliferative effects of taxol and arginine butyrate on human mesothelioma cells

S Emri, Y Koç, MC O'brien, D Sanders, S Tansan, F Foss Lung Cancer 11, 191

Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.

FM Foss, Y Koc, MA Stetler-Stevenson, DT Nguyen, MC O'Brien, R Turner, ... Journal of clinical oncology 12 (2), 326-335

Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon

S Tansan, S Emri, T Selçuk, Y Koç, P Hesketh, T Heeren, RP McCaffrey, ... Oncology 51 (4), 348-351

CORDYCEPIN ACTIVATES AN APOPTOTIC CASCADE IN TDT-

POSITIVE LEUKEMIA-CELLS

Y KOC, A URBANO, E SWEENEY, F FOSS, R MCCAFFREY BLOOD 82 (10), A115-A115

BIOMODULATORY EFFECTS OF BUTYRIC-ACID DERIVATIVES ON

LEUKEMIA AND LYMPHOMA-CELLS

FM Foss, Y Koc, D SANDERS, M OBRIEN, D FALLER, R McCaffrey Blood 82 (10), A564-A564

CONTINUOUS-INFUSION VERSUS BOLUS MITOXANTRONE IN

ACUTE NONLYMPHOBLASTIC LEUKEMIA

Y Koc, E Kansu, A Kars, Y OZISIK, G TEKUZMAN, E BALTALI, D FIRAT JOURNAL OF CHEMOTHERAPY 5, 672-673

Endothelin-1, 2 Levels in Behcet's disease 1993 E Kansu, Y Koc, Z Koray, S Duru

REVUE DE MEDECINE INTERNE 14, C 07-C 07

2005-2008 YILLARI ARASINDA KEMİK İLİĞİ TRANSPLANTASYONU 1993

YAPILAN HASTALARDA FEBRİL NÖTROPENİ ATAKLARINDAKİ KAN

KÜLTÜRLERİNDEN İZOLE EDİLEN MİKROORGANİZMALAR

Y GÜROL, Y ÖZTÜRK, ZT TEKKANAT, Y KOÇ, S KOCAGÖZ, G YILMAZ

C 07 Endothelin-1.2 levels in Behçet's disease

E Kansu, Y Koc, Z Koray, S Duru, F Batman, T Kansu, S Akkaya, B Elem, ... La Revue de Médecine Interne 14, 26s

Endothelin-1, 2 levels in Behcet's disease

Y Koc, E Kansu, Z Koray, S Duru

EXCERPTA MEDICA INTERNATIONAL CONGRESS SERIES 1037 (1), 97-97

Towards specific therapy in TdT-positive leukemia: Role of cordycepin 1993 Y KOÇ, RP McCAFFREY

Turkish Journal of Cancer 23 (4), 167-171

Familial Behçet's disease.

T Akpolat, Y Koç, I Yeniay, G Akpek, I Güllü, E Kansu, S Kiraz, F Ersoy, ... The European journal of medicine 1 (7), 391-395

Vascular involvement in Behcet's disease.

Y Koc, I Güllü, G Akpek, T Akpolat, E Kansu, S Kiraz, F Batman, T Kansu, ... The Journal of Rheumatology 19 (3), 402-410

Topical sucralfate therapy for oral ulcers in Behçet's disease: a

randomized double-blind study

Y Koç, G Akpek, T Akpolat, I Güllü, E Kansu, S Kiraz, F Batman, S Duru, ... Journal of dermatological treatment 3 (4), 197-199

71 1992

704 1992

1 1992

Aplastic anemia in a patient receiving tamoxifen. 1991 Y Koc, SA Kars, E Kansu, G Tekuzman, E Baltali, D Firat

International journal of hematology 54 (3), 263

Acute Lymphoblastic Leukemia in Breast Cancer: A Case Report 1991 Y KOÇ, SA KARS, E KANSU, D FIRAT

Turkish Journal of Cancer 21 (4), 151-153

Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.

E Kansu, Y Koc, A Kars, M Alakavuklar, G Tekuzman, D Firat Journal of chemotherapy (Florence, Italy) 1 (4 Suppl), 1268

Epidermal appendage tumors in xeroderma pigmentosum

SA Kars, Y Koç, Ş Ruacan, E Baltali, G Tekuzman, D Firat Archives of dermatology 123 (6), 713-714

Stem Hücre Transplantasyonunda Antiviral Tedavi ve Profilaksi

Y Koç

 

Üyelikler

American Society of Hematology (ASH) (1998-)

American Medical Association (AMA) (1998-)

European Bone Marrow Transplant Registry (EBMT) (2000-)

International Bone Marrow Transplant Registry (IBMTR) (2001-)

American Society of Bone Marrow Transplantation (ASBMT) (2002-)

International Society of Cellular Therapy (ISCT) (2002-)

Editorial Board, Turkish Journal of Cancer (2003-)

American Association of Blood Banks (AABB) (2004-)

JACIE Müfettişi, EBMT (2004-)

Kök Hücre Nakli ve Hücresel Tedavi Derneği Başkanı (2005-)

TÜBİTAK Proje Danışmanı (2006-)

Hücresel Tedavi ve Rejeneratif Tıp Derneği Kurucu Üyesi (2008-)

Editorial Board, Hakem, Lancet (2024-)